Skip to main content
Erschienen in: BMC Medicine 1/2022

Open Access 01.12.2022 | Research article

The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies

verfasst von: Zhanchen Liao, Zhitao Fang, Siqi Gou, Yong Luo, Yiqi Liu, Zhun He, Xin Li, Yansong Peng, Zheng Fu, Dongjin Li, Haiyun Chen, Zhigang Luo

Erschienen in: BMC Medicine | Ausgabe 1/2022

Abstract

Background

Evidence associating diet with the incidence of renal cell carcinoma (RCC) is inconclusive. We aimed to summarize evidence associating dietary factors with RCC incidence and assess the strength and validity of this evidence.

Methods

We conducted an umbrella review of systematic reviews or meta-analyses (SRoMAs) that assessed the association between diet and RCC incidence. Through April 2021, PubMed, Web of Science, Embase, The Cochrane Library, Scopus, and WCRF were searched. Two independent reviewers selected studies, extracted data, and appraised the quality of SRoMAs. According to credibility assessment criteria, evidence can be divided into five categories: convincing (class I), highly suggestive (class II), suggestive (class III), weak (class IV), and nonsignificant (class V).

Results

Twenty-nine meta-analyses were obtained after screening. After excluding 7 overlapping meta-analyses, 22 meta-analyses including 502 individual studies and 64 summary hazard ratios for RCC incidence were included: dietary patterns or dietary quality indices (n = 6), foods (n = 13), beverages (n = 4), alcohol (n = 7), macronutrients (n =15), and micronutrients (n =19). No meta-analyses had high methodological quality. Five meta-analyses exhibited small study effects; one meta-analysis showed evidence of excess significance bias. No dietary factors showed convincing or highly suggestive evidence of association with RCC in the overall analysis. Two protective factors had suggestive evidence (vegetables (0.74, 95% confidence interval 0.63 to 0.86) and vitamin C (0.77, 0.66 to 0.90)) in overall analysis. One protective factor had convincing evidence (moderate drinking (0.77, 0.70 to 0.84)) in Europe and North America and one protective factor had highly suggestive evidence (cruciferous vegetables (0.78, 0.70 to 0.86)) in North America.

Conclusions

Although many meta-analyses have assessed associations between dietary factors and RCC, no high-quality evidence exists (classes I and II) in the overall analysis. Increased intake of vegetables and vitamin C is negatively associated with RCC risk. Moderate drinking might be beneficial for Europeans and North Americans, and cruciferous vegetables might be beneficial to North Americans, but the results should be interpreted with caution. More researches are needed in the future.

Trial registration

Begleitmaterial
Additional file 2: Figure S1. Contour-enhanced funnel plots associating dietary patterns or diet quality indices with RCC incidence: A) healthy dietary pattern, B) unhealthy/Western pattern, C) drinking pattern, D) dietary inflammatory index, E) glycemic index, and F) glycemic load. Figure S2. Contour-enhanced funnel plots associating foods with RCC incidence: A) fish, B) vegetables, C) fruits, D) red meat, E) processed meat, and F) cruciferous vegetables. Figure S3. Contour-enhanced funnel plots associating foods with RCC incidence: A) poultry, B) all meat, C) fruit and non-starchy vegetables, D) non-starchy vegetables, E) tomatoes, and F) citrus fruit. Figure S4. Contour-enhanced funnel plots associating beverages with RCC incidence: A) sweet beverages (including artificially sweetened beverages and sugar-sweetened beverages), B) tea, C) coffee, and D) sweetened carbonated beverage. Figure S5. Contour-enhanced funnel plots associating alcoholic beverages with RCC incidence: A) beer, B) wine, C) spirits, D) alcohol (light), E) alcohol (moderate), F) alcohol (heavy), and G) alcohol (any). Figure S6. Contour-enhanced funnel plots associating macronutrients with RCC incidence: A) fruit fiber, B) vegetable fiber, C) cereal fiber, D) dietary fiber, E) Total fat, and F) saturated fat. Figure S7. Contour-enhanced funnel plots associating macronutrients with RCC incidence: A) monounsaturated fat, B) polyunsaturated fat, C) total protein, D) animal protein, and E) plant protein. Figure S8. Contour-enhanced funnel plots associating micronutrients with RCC incidence: A) riboflavin, B) vitamin B6, C) folate, D) vitamin B12, E) methionine, and F) choline. Figure S9. Contour-enhanced funnel plots associating micronutrients with RCC incidence: A) betaine, B) vitamin C, C) vitamin D, D) dietary nitrate, E) dietary nitrite, and F) vitamin E. Figure S10. Contour-enhanced funnel plots associating micronutrients with RCC incidence: A) alpha-carotene, B) beta-cryptoxanthin, C) lutein and zeaxanthin, D) dietary lycopene, E) total calcium (food and supplements), F) dietary calcium, and G) Calcium (supplements). Figure S11. After using the trim-and-fill method, contour-enhanced funnel plots for the association between A) vegetables, B) red meat, C) vegetable fiber, D) fruit and non-starchy vegetables, and E) lutein and zeaxanthin and the incidence of renal cell carcinoma were generated.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12916-021-02229-5.
Zhanchen Liao and Zhitao Fang authors contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AMSTAR
A MeaSurement Tool to Assess systematic Reviews
SRoMAs
Systematic reviews or meta-analyses
RCC
Renal cell carcinoma
CI
Confidence intervals
CCA
Corrected covered area
PI
Prediction intervals
SHR
Summary hazard ratios
O
The observed number
E
The expected number
NOS
The Newcastle-Ottawa Scale
ITC
Isothiocyanates
SFN
Sulforaphane
CYP
Cytochrome P450
TET
Ten eleven translocation
5mC
5-Methylcytosine
5hmC
5-Hydroxymethylcytosine

Background

Renal cell carcinoma (RCC) is the most fatal cancer of the urinary system and accounts for approximately 3% of all adult malignancies [1, 2]. The incidence of RCC is higher in developed countries [3, 4]. From 2013 to 2017, the incidence of RCC showed an increasing trend, with an average annual increase of 1.4% in men (average annual percent change=1.4%, 95% confidence interval, CI =1.0 to 1.7%) and 1.6% in women (1.6%, 0.6 to 2.7%) [5]. In 2020, there were approximately 430,000 new RCC cases and 180,000 deaths worldwide [6]. In 2021, it is estimated that approximately 76,000 new cases of RCC and 13,000 deaths will occur in the USA [7].
Treatment of RCC results in a heavy financial burden. According to the 2017 French health insurance database, the cost of targeted therapy for patients with advanced RCC is €5546/person/month [8]. Therefore, effective prevention and management of RCC are necessary to significantly reduce the financial burden for the country and patients’ family and is of great public health importance. Although many factors (including diet) have been suggested to be associated with the incidence of RCC, the conclusions are inconsistent [9].
Numerous studies have shown that diet is inextricably linked to the tumorigenesis of RCC [1014]. Evidence regarding the association of various dietary factors, such as red meat, vegetables, and vitamin B6, with the risk of RCC has been summarized in published SRoMAs. These discoveries could have important implications for RCC prevention. However, the strength and validity of this evidence and whether there is a potential risk of bias still need to be further evaluated and analyzed. In addition, previously published meta-analyses associating a specific dietary factor with RCC incidence have had conflicting findings. For example, previously published meta-analyses investigated the correlation between red meat and processed meat intake and the incidence of RCC [1518]. According to Alexander and Lee, red meat and processed meat consumption were not related to the risk of RCC [16, 18], whereas Faramawi and Zhang concluded that eating more red meat and processed meat increased the risk of RCC [15, 17]. Furthermore, the associations reported in these studies may be causal, but the effect of these diets on RCC risk could be overstated because of the inherent bias associated with inevitable confounding factors and selective reporting of positive results [1922].
To summarize and assess the strength and validity of the available evidence and to evaluate its quality, an umbrella review of SRoMAs of observational studies was conducted to investigate the associations between various dietary factors (including dietary patterns or dietary quality indices, different foods, beverages, alcohol, and various nutrients) and the incidence of RCC. A systematic evaluation of the available data from published SRoMAs on a particular research issue is referred to as an umbrella review [2332]. Umbrella reviews can assess the strength and validity of the evidence in the published SRoMAs and evaluate the potential for risk of bias [33].

Methods

The protocol was registered in PROSPERO (registration number: CRD42021246619), and our search strategy followed the PRISMA 2020 statement: an updated guideline for reporting systematic reviews [34].

Inclusion and exclusion criteria

The inclusion criteria were as follows: (1) dose-response or high vs low SRoMAs of observational studies (including case-control studies, prospective cohort studies, or pooled studies); (2) SRoMAs reporting odds ratios, relative rates, risk ratios, or hazard ratios as effect sizes, and SRoMAs including summary hazard ratios (SHRs) and 95% CIs. PICO definitions: (1) population: people of any sex, age, source of cases, country, and ethnicity; (2) intervention: dietary factors including various foods, dietary patterns, dietary quality index, beverages, alcohol, macronutrients, and micronutrients (see Additional file 1: Table S1); (3) comparator: the abovementioned dietary factors versus no dietary factors or varying levels of dietary factors (dose-response or high vs low); and (4) outcome: patients with RCC.
Studies that met any of the following criteria were excluded: (1) individual study, (2) animal or experimental study, (3) conference literature, (4) editorial, (5) systematic review without meta-analysis (i.e., no combined effect size), (6) meta-analysis of individual patient data, (7) exposures were plasma levels or biomarkers, and (8) diseases were other urologic tumors.

Search strategy

PubMed, Web of Science, Embase, Scopus, and The Cochrane Library were systematically searched using a predefined search strategy from inception until April 2021. We also manually searched World Cancer Research Fund (WCRF) for their SRoMAs, which was rigorously conducted by their groups of experts. The language was limited to English. The literature search was conducted independently by two reviewers (ZCL, ZTF). Disagreements during the search process were resolved by consensus through discussion. A detailed search strategy for the Embase database has been provided in Additional file 1: Table S1. The Cohen kappa analysis was performed to measure the level of agreement between the reviewers on the selection of eligible studies.

Study selection and data extraction

Study selection and data extraction were conducted by one author (ZCL) and double-checked by another author (ZTF). When a disagreement emerged, a consensus was reached through discussion. For each published SRoMA, data extracted included the title, first author, year of publication, exposures (including doses), number and types of individual studies included, type of effect model, sample size (participants and cases), type of meta-analysis metric, summary estimated effect (odds ratios, relative rates, risk ratios, or hazard ratios) and 95% CI, type of comparison, quality appraisal tool for the individual study, publication bias, heterogeneity, funding information, and conflict of interest. For SRoMAs examining the associations between a specific dietary factor and multiple diseases or health outcomes, only data related to RCC were extracted.
The following data were extracted from individual studies in a SRoMA: first author, publication year, exposures (including doses), sample size (participants and cases), summary estimated effect that adjusted for the most confounders and 95% CI, and adjusted covariates. According to the literature, the most important potential confounders in the investigation between dietary factors and the risk of RCC include age, sex, smoking, BMI, total energy intake, alcohol intake, and physical activity. We utilized the form of the Joanna Briggs Institute as our data extraction guide (see Additional file 1: Table S2) [35]. The effect sizes and 95% CI were used to estimate small study effects and excess significant bias. If the data were not available in the articles and appendices, the author were contacted to request the missing information.

Assessment of methodological quality

SRoMAs that satisfied the inclusion criteria were appraised by one author (ZCL) utilizing the AMSTAR 2 online quality appraisal instrument and providing an overall rating for the SRoMAs included [36, 37]. Verification of the quality assessment process was performed by another author (ZTF). Disagreements were addressed by discussion and consensus.
AMSTAR 2 is a reliable and validated methodological quality appraisal instrument with 16 items [38]. Seven of these items are critical. These 7 critical items are whether the protocol was registered before starting the systematic review, whether a comprehensive and adequate literature search was conducted, whether the exclusion of individual studies was justified, whether the risk of bias of the individual studies included in the systematic review was adequately assessed, what statistical procedures were employed in the meta-analysis and whether or not they were appropriate, whether the risk of bias was adequately considered when analyzing the results of the systematic review, and whether publication bias and its possible impact were adequately assessed [36].

Outdated and overlapping publications

SRoMAs are continually updated by incorporating relevant evidence from new studies to maintain validity and applicability. Otherwise, there would be a risk of inaccurate evidence or even a situation where erroneous evidence misleads decision-makers or researchers [3942]. Moreover, different investigators or research institutions perform SRoMAs of the same exposure and population. Therefore, there can be two or more overlapping SRoMAs on the same research topics [43, 44]. Some studies have reported that up to 2/3 of published SRoMAs overlap at least partially or completely [45]. Inclusion of data from overlapping SRoMAs would lead to a risk of bias, resulting in inaccurate results and estimates [46, 47]. In addition, considering that up to 50% of published systematic reviews become outdated after 5.5 years [42], we used 2015 as the cutoff year. We referred to overlapping SRoMAs published before 2015 as outdated overlapping SRoMAs and overlapping SRoMAs published after 2015 as contemporary overlapping SRoMAs. If a contemporary SRoMA overlapped with an outdated SRoMA, the outdated SRoMA was excluded.
As in the previous umbrella review [26], in the case of contemporary overlapping SRoMAs, we used the citation matrix (graphical cross tabulation) recommended by Bougioukas et al. to show the degree of overlap [44]. The corrected covered area (CCA) was used to quantify the degree of overlap of the citation matrix [43]. The degree of overlap was labeled as slight, moderate, high, or very high, corresponding to CCAs of 0 to 5%, 6 to 10%, 11 to 15%, and greater than 15%, respectively. Details of the overlapping SRoMAs have been shown in Additional file 1: Table S3. The selection of overlapping SRoMAs will be based on the following principles: (1) if the overlapping publications were derived from both Cochrane systematic reviews and non-Cochrane systematic reviews, the former was preferred [48] because these tended to be more up-to-date and of higher quality than the latter [49]; (2) if the overlapping publications were derived from non-Cochrane systematic reviews and the degree of overlap was high or very high, the following SRoMAs were preferred: the reviews with the best methodological quality after assessment with AMSTAR 2, the most recently published reviews, the reviews with the largest number of individual studies included, or the reviews with the largest number of participants [48]; and (3) if the degree of overlap was moderate or slight, both reviews were retained.
If the overlapping SRoMAs were all outdated, discarding them directly would result in inadequate data utilization, which would lead to a risk of bias and inaccurate results, so the outdated overlapping SRoMAs were selected according to the 3 principles mentioned above for managing contemporary overlapping SRoMAs.

Credibility assessment

As in previous umbrella reviews [23, 24, 27, 29, 30], we classified evidence associating diet and RCC incidence into 5 categories. Evidence was judged to be convincing (class I) if the following criteria were met: statistically significant results were observed for both the association and the largest study (p<10-6 and p<0.05, respectively), the number of cases exceeded 1000 or the number of participants for consecutive outcomes exceeded 20,000, there was low heterogeneity (I2<50%), the 95% prediction interval (PI) did not include a null value, there was no excess significance bias, and there were no small study effects (“p<0.10 of Egger’s regression” plus “the random-effects summary estimate being larger than the point estimate of the largest study in the meta-analysis” can be considered as small study effects). Evidence was judged to be highly suggestive (class II) if the following criteria were met: statistically significant results were observed for both the association and the largest study (p<10-6 and p<0.05, respectively); and the number of cases exceeded 1000 or the number of participants for consecutive outcomes exceeded 20,000. Evidence was judged to be suggestive (class III) if the following criteria were met: associations with statistical significance were observed for the association (p<10-3); the number of cases exceeded 1000 or the number of participants for consecutive outcomes exceeded 20,000. Evidence was judged to be weak (class IV) if it met the criterion of a statistically significant association (p<0.05). The evidence was judged to be nonsignificant (class V) if no statistically significant association was observed (p≥0.05)

Statistical analysis

Assessment of SHR

We recalculated the SHR and corresponding 95% CI for the included SRoMAs for each exposure using the Sidik and Jonkman random-effects model [50, 51], which is recommended by the Cochrane handbook. It takes into account heterogeneity both within and between studies and adjusts the confidence interval [50, 51]. There may be high heterogeneity in the definition of a specific dietary factor and the sample characteristics of the individual studies included in the SRoMAs, and most of the included SRoMAs used random-effects model for combining effect sizes. To establish comparability with these previously published SRoMAs, we also adopted this approach. If the included SRoMAs were divided into two subgroups by sex or race to obtain hazard ratios, we combined the hazard ratios of the two subgroups using a fixed effects model before calculating the SHR and corresponding 95% CI [52].
If both dose-response and high vs low SRoMAs were available, we recalculated the SHR and corresponding 95% CI only for the SRoMA with the highest number of included individual studies. If data related to the dose-response SRoMAs were missing, we calculated the SHR and corresponding 95% CI for the high vs low SRoMAs. If data could not be extracted from the SRoMAs, we could not recalculate the SHR and corresponding the 95% CI, and therefore, we directly used the SHR and 95% CI from the included SRoMAs.
We considered that dietary factors were not associated with the incidence of RCC if the 95% CI included a null value or an SHR of 1. We used the meta package in R to calculate the SHR, 95% CI, and p value for each exposure [53].

Assessment of heterogeneity

We used I2 to assess the heterogeneity of each published SRoMA. I2 values range from 0 to 100% and are used as a measure of the magnitude of heterogeneity among individual studies and can be used to present the percentage of the total variance caused by heterogeneity [54]. I2 <50% can be considered nonsignificant heterogeneity. τ2 was also calculated, which can explain the between-study variance associated with risk estimates because I2 is affected by study size [55]. In addition, we calculated a 95% PI for the SHR, which further explains the heterogeneity among studies. This interval with 95% certainty provides a prediction range for the potential true effect size of future studies [55]. The I2, τ2, and 95% PI for each published SRoMA were calculated with the meta package in R [53].

Assessment of publication bias and small study effects

For published SRoMAs, contour-enhanced funnel plots were used to assess whether indications of publication bias existed [56]. The presence of missing studies in areas of the plot without significant differences suggests that the funnel plot asymmetry may be due to publication bias; the presence of missing studies in areas with significant differences suggests that the asymmetry may be due to other causes, such as heterogeneity [57], rather than publication bias [56].
Egger’s regression asymmetry test was employed to see if indications of small study effects existed (i.e., small studies provide greater effect size estimates than large studies) [57]. As in prior umbrella reviews [2325], a p value<0.10 with a more conservative effect in the largest study (the study with the smallest standard error) than in the random-effects meta-analysis was deemed to be indicative of small study effects. To estimate true effects, the “trim-and-fill” approach was applied when Egger’s test was statistically significant [58]. The contour-enhanced funnel plots, Egger’s test, and the trim-and-fill method were conducted with the meta and metafor packages in R [53, 59].

Assessment of excess significance bias

Based on a chi-square test, the excess significance test was used to assess whether the observed number of statistically significant studies (O) exceeded the expected number of statistically significant studies (E) [60, 61]. For the excess significance test, assuming that the true effect size is consistent with that of the largest study in the SRoMA, we calculated the statistical power of each individual study based on an algorithm that applies a noncentral t distribution [62]. The expected number (E) was calculated by adding the estimated statistical power of each individual study together. A p value<0.10 (two-tailed) for the observed number (O) > expected number (E) implies an excess significance bias, as described in previously published umbrella reviews [23, 24, 27]. The excess significance bias test was conducted with the metaviz package in R [63].

Subgroup analysis and sensitivity analysis

Where sample sizes permitted, subgroup analyses were performed by region and study design. For associations with evidence levels of classes I to III, we performed sensitivity analyses by removing small-sized studies and low-quality studies which were defined in the included SRoMA. We conducted all statistical analyses in R (version 4.0.5).
Patient involvement
There were no patients involved in any part of this umbrella review, including establishing the research questions, outcome measures, study design, or implementation; interpretation of results; and suggestions for manuscript writing. We will disseminate the results through social media and relevant conferences.

Results

A total of 1587 publications were identified in six databases, and 1029 publications were obtained after excluding duplicates. After title and abstract screening, 86 publications required full-text screening. Twenty-nine published meta-analyses were obtained after full-text screening [1518, 6488]. After excluding 7 overlapping publications, 22 meta-analyses were ultimately included (kappa=0.87) [1517, 6481, 87]. The literature selection procedure is shown in Fig. 1, and details of the studies excluded after full-text screening and the reasons for exclusion are provided (see Additional file 1: Table S4) [18, 8286, 88145]. Twenty-two published meta-analyses included 502 individual studies and 64 SHRs for the incidence of RCC: dietary patterns or dietary quality indices (n=6), foods (n=13), beverages (n=4), alcohol (n=7), macronutrients (n=15), and micronutrients (n=19).
We identified the following exposures associated with the incidence of RCC: healthy dietary pattern [64], unhealthy/Western pattern [64], drinking pattern [64], fish [65], total fat [87], sweetened carbonated beverage [66], beer [67], wine [67], spirits [67], riboflavin [68], vitamin B6 [68], folate [68], vitamin B12 [68], saturated fat [87], methionine [68], choline [68], betaine [68], all meats [15], tea [69], fruit fiber [70], vegetable fiber [70], cereal fiber [70], legume fiber [70], dietary inflammatory index [71], vitamin C [72], seafood [16], animal fat [16], cholesterol [16], total protein [87], animal protein [87], plant fat [16], plant protein [87], sweetened beverages (including artificially sweetened beverages and sugar-sweetened beverages) [73], polyunsaturated fat [87], vitamin E [74], coffee [75], vitamin D [76], dietary nitrate [77], dietary nitrite [77], glycemic index [78], glycemic load [78], monounsaturated fat [87], dietary fiber [78], alcohol (light) [79], alcohol (moderate) [79], alcohol (heavy) [79], alcohol (any) [79], vegetables [80], fruit [80], red meat [17], processed meat [17], cruciferous vegetables [81], poultry [15, 16], fruit and non-starchy vegetables [87], non-starchy vegetables [87], tomatoes [87], citrus fruit [87], alpha-carotene [87], beta-cryptoxanthin [87], lutein and zeaxanthin [87], dietary lycopene [87], total calcium (food and supplements) [87], dietary calcium [87], and calcium (supplements) [87].

Characteristics of the included meta-analyses

The overall characteristics of the 22 meta-analyses that were included in the umbrella review are summarized in Table 1. The first authors of the meta-analyses were from China, France, Iran, Spain, the UK, and the USA. The populations in the individual studies included in the meta-analyses were from Asia, North America, South America, Europe, and Oceania. The umbrella review included a total of 502 individual studies, of which 59% were cohort studies (n=298), 39% were case-control studies (n=196), and 2% were pooled studies (n=8).
Table 1
Overall characteristics of meta-analyses included in the umbrella review
Author/Year
Country
Exposure (including dose of exposure)
No. of included studies
Cohort
Case control
Pooled study
Effects model
No. of participants/no. of cases
MA metric
Comparison
Range/amount
Quality appraisal tool
Information on funding
Conflict of interests
Alizadeh 2017 [64]
Iran
Healthy dietary pattern
4
1
3
0
fixed
51,709/1327
OR
High vs low
Higher adherence vs lower adherence
NOS
NA
No
Unhealthy/western pattern
4
1
3
0
51,709/1327
OR
Drinking pattern
2
1
1
0
47,705/554
OR
Bai 2013 [65]
China
Fish
15
3
12
0
fixed
608,753/9324
RR
High vs low
Higher adherence vs lower adherence
NOS
No
No
Boyle 2014 [66]
France
Sweetened carbonated beverage
5
2
2
1
random
NA/NA
RR
High vs low
Higher adherence vs lower adherence
NA
Yes
No
Cheng 2011 [67]
China
Beer
8
0
8
0
fixed
NA/5538
OR
High vs low
Higher adherence vs lower adherence
NA
NA
NA
Wine
8
0
8
0
random
NA/5538
OR
Spirits
9
0
9
0
random
NA/6393
OR
Clasen 2020 [68]
UK
Riboflavin
3
1
2
0
Bayesian
39,789/1971
RR
High vs low
Higher adherence vs lower adherence
NOS
Yes
No
Vitamin B6
5
3
2
0
164,883/2407
RR
Folate
6
2
4
0
136,319/3166
RR
Vitamin B12
3
2
1
0
127,390/1578
RR
Methionine
2
2
0
0
125,094/436
RR
Choline
2
2
0
0
125,094/436
RR
Betaine
2
2
0
0
125,094/436
RR
Faramawi 2007 [15]
USA
All meat
11
0
11
0
fixed
15,237/4835
OR
High vs low
Higher adherence vs lower adherence
NA
NA
NA
Hu 2013 [69]
China
Tea
12
2
10
0
random
1,571,852/6636
RR
High vs low
Higher adherence vs lower adherence
NA
Yes
NA
Huang 2014 [70]
China
Fruit fiber
3
1
2
0
random
496,292/2906
RR
High vs low
Higher adherence vs lower adherence
NOS
NA
No
Vegetable fiber
3
1
2
0
496292/2906
RR
Cereal fiber
3
1
2
0
496,292/2906
RR
Legume fiber
1
1
0
0
491,841/1816
RR
Jayedi 2018 [71]
Iran
Dietary Inflammatory Index
2
1
1
0
random
36,118/1030
RR
Dose-response
1-unit increment
NOS
No
No
Jia 2015 [72]
China
Vitamin C
10
3
7
0
fixed
274,864/5182
RR
High vs low
Higher adherence vs lower adherence
NA
NA
No
Lee 2008 [16]
USA
Total fat
13
13
0
0
random
774,952/1478
RR
High vs low
Higher adherence vs lower adherence
NA
YES
NA
Saturated fat
13
13
0
0
774,952/1478
RR
Monounsaturated fat
13
13
0
0
774952/1478
RR
Polyunsaturated fat
13
13
0
0
774952/1478
RR
Animal fat
8
8
0
0
417,093/900
RR
Plant fat
8
8
0
0
417,093/900
RR
Cholesterol
13
13
0
0
774,952/1478
RR
Total protein
13
13
0
0
774,952/1478
RR
Animal protein
8
8
0
0
530,410/1019
RR
Plant protein
8
8
0
0
530,410/1019
RR
Poultry
12
12
0
0
NA/1407
RR
Seafood
12
12
0
0
NA/1375
RR
Llaha 2021 [73]
Spain
Sweet beverages (include ASB and SSB)
3
1
2
0
random
143,194/1589
RR
High vs low
Higher adherence vs lower adherence
ROBINS-E NOS
Yes
No
Shen 2015 [74]
China
Vitamin E
13
6
7
0
NA
471,006/6944
RR
High vs low
Higher adherence vs lower adherence
NA
Yes
No
Wijarnpreecha 2017 [75]
USA
Coffee
22
6
16
0
random
1,991,863/NA
RR
High vs low
Higher adherence vs lower adherence
NOS
No
No
Wu 2020 [76]
China
Vitamin D
6
3
3
0
fixed
187,560/NA
RR
High vs low
Higher adherence vs lower adherence
NOS
NA
No
Xie 2016 [77]
China
Dietary nitrate
3
2
1
0
random
NA/NA
RR
high vs low
Higher adherence vs lower adherence
NO
NA
No
Dietary nitrite
2
1
1
0
fixed
NA/NA
RR
Xu 2019 [78]
China
Dietary fiber
7
2
5
0
random
942,582/6590
RR
high vs low
Higher adherence vs lower adherence
NOS
Yes
No
Glycemic index
5
2
3
0
502,119/4281
RR
Glycemic load
5
2
3
0
502119/4281
RR
Xu 2015 [79]
China
Alcohol (light)
6
5
0
1
random
3,720,850/5214
RR
Light
<12.5 g/day (<1 drink/day)
NOS
Yes
No
Alcohol (moderate)
8
7
0
1
4,139,301/5364
RR
Moderate
12.5–37.5 g/day (2–3 drinks/day)
Alcohol (heavy)
3
3
0
0
2,065,995/363
RR
Heavy
>37.5 g/day (>3 drinks/day)
  
Alcohol (any)
8
7
0
1
 
4,867,646/5503
RR
High vs low
Higher adherence vs lower adherence
   
Zhang 2017 [80]
China
Vegetables
16
2
13
1
random
1,365,634/9353
RR
High vs low
Higher adherence vs lower adherence
NOS
NA
No
Fruits
17
3
13
1
1,398,778/9150
RR
Zhang 2017 [17]
China
Red meat
19
4
14
1
random
1,826,171/12631
RR
High vs low
Higher adherence vs lower adherence
NOS
NA
No
Processed meat
19
3
15
1
1,793,675/14240
RR
Zhao 2013 [81]
China
Cruciferous Vegetables
12
6
6
0
random
1,228,518/5773
RR
High vs low
Higher adherence v lower adherence
NOS
No
No
WCRF 2013 [87]
UK
Fruit and non-starchy vegetables
7
7
0
0
random
756,544/1215
RR
Dose-response
Per 100 g/d
NA
Yes
NA
Non-starchy vegetables
8
8
0
0
1,248,385/3031
Dose-response
Per 100 g/d
Tomatoes
3
3
0
0
NA/427
Dose-response
Per 50 g/d
Citrus fruit
7
7
0
0
NA/2735
Dose-response
Per 50 g/d
Total fat
14
14
0
0
1,210,245/1985
Dose-response
5% energy
Saturated fat
14
14
0
0
1,210,245/1985
Dose-response
5% energy
Monounsaturated fat
14
14
0
0
1,210,245/1985
Dose-response
5% energy
Polyunsaturated fat
14
14
0
0
1,210,245/1985
Dose-response
5% energy
Total protein
14
14
0
0
1,210,245/1985
Dose-response
5% energy
Animal protein
14
14
0
0
1,210,245/1985
Dose-response
5% energy
Plant protein
14
14
0
0
1,210,245/1985
Dose-response
5% energy
Alpha-carotene
4
4
0
0
284,501/787
Dose-response
Per 600 μg/d
Beta-cryptoxanthin
4
4
0
0
284,501/787
Dose-response
Per 100 μg/d
Lutein and zeaxanthin
4
4
0
0
284,501/787
Dose-response
Per 1000 μg/d
Lycopene
4
4
0
0
284,501/787
Dose-response
Per 4000 μg/d
Total calcium (food and supplements)
3
3
0
0
NA/1711
Dose-response
Per 200 mg/d
Dietary calcium
3
3
0
0
NA/1574
Dose-response
Per 200 mg/d
Calcium from supplements
3
3
0
0
NA/1482
High vs low
Higher adherence v lower adherence
MA meta-analysis, NA not available, NOS Newcastle-Ottawa Scale, ROBINS-E risk of bias in non-randomized studies—of exposures, OR odds ratio, RR risk ratio, UK The United Kingdom, USA The United States of America, ASB artificially sweetened beverages, SSB sugar-sweetened beverages
Except for legume fiber, the meta-analyses of each exposure included 7 (range 2–22) individual studies. Of the meta-analyses corresponding to the 64 exposures, 33% (n=21) were dose-response meta-analyses (dietary inflammatory index, alcohol (light), alcohol (moderate), alcohol (heavy), total fat, saturated fat, monounsaturated fat, polyunsaturated fat, total protein, animal protein, plant protein, fruit and non-starchy vegetables, non-starchy vegetables, tomatoes, citrus fruit, alpha-carotene, beta-cryptoxanthin, lutein and zeaxanthin, dietary lycopene, total calcium (food and supplements), dietary calcium), and 67% (n=43) were high vs low meta-analyses. Of the 64 exposures, 73% (n=47) of the meta-analyses combined hazard ratios by using a random effects model, 14% (n=9) used a fixed effects model to combine hazard ratios, 11% (n=7) used a Bayesian model to combine hazard ratios, and 2% (n=1) did not provide this information. Of the 22 meta-analyses, 59% (n=13) used the Newcastle-Ottawa Scale (NOS) to assess the methodological quality of the individual studies, one of which used “the Risk Of Bias In Non-randomized Studies—of Exposures” tool in addition to the NOS to assess the methodological quality of the individual studies, and 41% (n=9) did not report a relevant methodological quality assessment instrument (n=8) or did not use a relevant tool to assess methodological quality (n=1).

Methodological quality

Detailed information on the methodological quality of the 29 meta-analyses assessed using ASMTAR 2 has been provided (see Additional file 1: Table S5) [1518, 6488]. Of the 29 meta-analyses, none were rated as having high methodological quality, 34% (n=10) were rated as moderate, 38% (n=11) were rated as low, and 28% (n=8) were rated as critically low. Most of the 11 low-quality meta-analyses did not meet the 3 critical items in AMSTAR 2, which were failure to state that the protocol was registered before conducting the meta-analysis, failure to conduct a comprehensive and adequate search, and failure to provide a summary of excluded publications and give reasons for exclusion. In addition to the 3 critical items mentioned above, the 8 critically low-quality meta-analyses largely failed to meet the following 2 critical items: the risk of bias of individual studies was not assessed using appropriate instruments, and the appropriate statistical methods were not used to combine hazard ratios when performing a meta-analysis [36].

Overlapping and nonoverlapping associations

Seven meta-analyses reported overlapping associations between dietary factors and the incidence of RCC [18, 8286, 88]. There were 8 associations with varying degrees of overlap. Fifty percent (n=4) of the associations identified in the overlapping meta-analyses were consistent in their orientation and magnitude. These associations were with the following factors: dietary fiber [70, 78], cruciferous vegetables [81, 84], vitamin E [74, 85], and coffee [75, 83]. However, 50% (n=4) of the directions and magnitudes of the associations were inconsistent, and these associations were with the following factors: red meat [1518], processed meat [1518], alcohol [67, 79, 82, 86, 88], and poultry [15, 16]. The details of the meta-analyses of overlapping exposures, which contain the AMSTAR 2 ratings and the decision to retain or exclude each meta-analysis, are presented in Additional file 1: Table S6 [1518, 70, 74, 75, 78, 79, 8186, 88, 95]. Detailed information on the overlap of each association assessed with the citation matrix and CCA is shown in Additional file 1: Table S3. A list of the 22 meta-analyses included in this umbrella review and the 7 meta-analyses excluded due to overlap is provided (see Additional file 1: Table S7) [15, 16, 18, 6488].

Associations and level of evidence

The SHR and level of evidence for each dietary factor are summarized in Table 2 and are shown in Figs. 2, 3, 4, 5, 6, and 7. The SHR and 95% CI excluded the null value for 20 of the 64 exposures, including 4 (67%) for dietary patterns or dietary quality indices; 6 (46%) for foods; 0 for beverages; 3 (42%) for alcoholic beverages; 3 (20%) for macronutrients; and 4 (21%) for micronutrients. The SHR was statistically significant (P<0.05) for 18 (28%) of the 64 exposures, with 4 (67%) exposures for dietary patterns or dietary quality indices, 6 (46%) for foods with 1 (8%) that were unavailable due to missing data, 0 for beverages, 2 (29%) for alcoholic beverages, 2 (13%) for macronutrients with 4 (27%) that were unavailable due to missing data, and 4 (21%) for micronutrients. Sixty (94%) exposures in the included meta-analyses had more than 1000 cases or 20,000 participants.
Table 2
Evidence of associations between diet and renal cell carcinoma
Exposure
Reference
No of primary studies
No. of participants/no. of cases
Adjusted SHR (95%-CI)
P value
I2
95%-PI
Small study effects
Excess significance bias
Largest study significant
Level of evidence
Dietary patterns or dietary quality indices
Healthy dietary pattern
Alizadeh 2017
4
51,709/1327
0.66 (0.51 to 0.85)
0.001449
19.4%
0.27 to 1.63
No
No
No
IV
Unhealthy/Western pattern
Alizadeh 2017
4
51,709/1327
1.54 (1.19 to 2.01)
0.001232
24.70%
0.62 to 3.84
No
No
No
IV
Drinking pattern
Alizadeh 2017
2
47,705/554
0.69 (0.47 to 1.01)
0.057101
0.00%
NA
NA
No
No
NS
Dietary Inflammatory Index
Jayedi 2018
2
36,118/1030
1.08 (1.03 to 1.13)
0.00276
0.00%
NA
NA
No
No
IV
Glycemic index
Xu 2019
5
502,119/4281
1.18 (1.02 to 1.37)
0.026826
26.00%
0.79 to 1.75
No
No
No
IV
Glycemic load
Xu 2019
5
502,119/4281
1.16 (0.73 to 1.84)
0.522525
82.40%
0.21 to 6.45
No
No
No
NS
Foods
Fish
Bai 2013
15
608,753/9324
0.97 (0.84 to 1.10)
0.612245
24.10%
0.63 to 1.47
No
No
No
NS
All meat
Faramawi 2007
11
15,237/4835
1.27 (1.08 to1.49)
0.003529
0.00%
0.83 to 1.94
No
No
No
IV
seafood*
Lee 2008
12
NA/1375
1.05 (0.82 to 1.35)
NA
NA
NA
NA
NA
NA
-
Vegetables
Zhang 2017
16
1,365,634/9353
0.74 (0.63 to 0.86)
0.000073
51.30%
0.44 to 1.23
Yes
No
Yes
III
Fruits
Zhang 2017
17
1,398,778/9150
0.84 (0.69 to 1.02)
0.075352
50.90%
0.39 to 1.78
No
No
Yes
NS
Red meat†
Zhang 2017
19
1,826,171/12631
1.40 (1.15 to 1.70)
0.000807
71.40%
0.63 to 3.13
Yes
No
No
III
Processed meat
Zhang 2017
19
1,793,675/14240
1.13 (1.01 to 1.26)
0.030876
46.80%
0.78 to 1.64
No
No
No
IV
Poultry#
Faramawi 2007;
Lee 2008
16
NA/4165
1.23 (1.02 to 1.47)
0.030824
0.00%
0.88 to 1.70
No
No
Yes
IV
Cruciferous vegetables
Zhao 2013
12
1,228,518/5773
0.81 (0.71 to 0.92)
0.001107
55.70%
0.54 to 1.20
No
No
Yes
IV
Fruit and non-starchy vegetables
WCRF 2013
7
756,544/1215
0.99 (0.93 to 1.05)
0.748236
0.00%
0.85 to 1.15
Yes
No
No
NS
Non-starchy vegetables
WCRF 2013
8
1,248,385/3031
0.99 (0.91 to 1.09)
0.942029
0.00%
0.80 to 1.24
No
No
No
NS
Tomatoes
WCRF 2013
3
NA/427
1.11 (0.92 to 1.35)
0.28285
0.00%
0.27 to 4.51
No
No
No
NS
Citrus fruit
WCRF 2013
7
NA/2735
0.98 (0.90 to 1.05)
0.53534
0.00%
0.80 to 1.19
No
No
Yes
NS
Beverages
Sweetened carbonated beverage
Boyle 2014
5
NA/NA
1.35 (0.86 to 2.11)
0.187219
60.10%
0.28 to 6.51
No
No
NA
NS
Sweet beverages (include ASB and SSB)
Llaha 2021
3
143,194/1589
1.33 (0.74 to 2.40)
0.336717
85.60%
0.0008 to 2156.90
No
No
No
NS
Tea
Hu 2013
12
1,571,852/6636
1.05 (0.83 to 1.33)
0.680841
71.50%
0.44 to 2.49
No
No
No
NS
Coffee
Wijarnpreecha 2017
22
1,991,863/NA
0.99 (0.84 to 1.18)
0.949021
32.60%
0.50 to 1.98
No
No
No
NS
Alcoholic beverages
Beer
Cheng 2011
8
NA/5538
0.84 (0.70 to 1.00)
0.052184
14.80%
0.52 to 1.34
No
No
No
NS
Wine
Cheng 2011
8
NA/5538
0.70 (0.52 to 0.94)
0.019297
56.00%
0.30 to 1.70
No
No
Yes
IV
Spirits
Cheng 2011
9
NA/6393
0.80 (0.64 to 0.99)
0.048382
74.30%
0.39 to 1.62
No
No
Yes
IV
Alcohol (light)
Xu 2015
6
3,720,850/5214
0.91 (0.81 to 1.02)
0.102662
39.60%
0.64 to 1.28
No
No
No
NS
Alcohol (moderate)
Xu 2015
8
4,139,301/5364
0.77 (0.58 to 1.02)
0.069063
29.20%
0.30 to 1.98
No
No
Yes
NS
Alcohol (heavy)
Xu 2015
3
2,065,995/363
0.93 (0.27 to 3.22)
0.9134
81.20%
0.0000 to 3904180.81
No
Yes
Yes
NS
Alcohol (any)
Xu 2015
8
4,867,646/5503
0.88 (0.63 to 1.22)
0.439292
62.90%
0.27 to 2.81
No
Yes
Yes
NS
Macronutrients
Fruit fiber
Huang 2014
3
496,292/2906
0.91 (0.74 to 1.11)
0.346662
0.00%
0.14 to 6.06
No
No
No
NS
Vegetable fiber
Huang 2014
3
496,292/2906
0.68 (0.44 to 1.06)
0.089923
76.90%
0.003 to 139.60
Yes
No
No
NS
Cereal fiber
Huang 2014
3
496,292/2906
1.05 (0.88 to 1.26)
0.569512
0.00%
0.22 to 4.94
No
No
No
NS
Legume fiber*
Huang 2014
1
491,841/1816
0.80 (0.69 to 0.93)
NA
NA
NA
NA
NA
NA
-
Total fat
WCRF 2013
14
1,210,245/1985
1.02 (0.98 to 1.07)
0.360753
0.00%
NA
NA
No
No
NS
Saturated fat
WCRF 2013
14
1,210,245/1985
1.05 (0.88 to 1.24)
0.60759
41.30%
NA
NA
No
No
NS
Monounsaturated fat
WCRF 2013
14
1,210,245/1985
0.98 (0.83 to 1.15)
0.762472
0.00%
NA
NA
No
No
NS
Polyunsaturated fat
WCRF 2013
14
1,210,245/1985
0.90 (0.75 to 1.07)
0.219824
18.90%
NA
NA
No
No
NS
Animal fat*
Lee 2008
8
417,093/900
1.01 (0.96 to 1.07)
NA
NA
NA
NA
NA
NA
-
Plant fat*
Lee 2008
8
417,093/900
0.99 (0.93 to 1.05)
NA
NA
NA
NA
NA
NA
-
Cholesterol*
Lee 2008
13
774,952/1478
1.03 (0.94 to 1.14)
NA
NA
NA
NA
NA
NA
-
Total protein
WCRF 2013
14
1,210,245/1985
1.08 (0.99 to 1.19)
0.09981
0.00%
NA
NA
No
No
NS
Animal protein
WCRF 2013
14
1,210,245/1985
1.10 (1.00 to 1.20)
0.04936
0.00%
NA
NA
No
No
IV
Plant protein
WCRF 2013
14
1,210,245/1985
0.98 (0.80 to 1.22)
0.88739
0.00%
NA
NA
No
No
NS
Dietary fiber
Xu 2019
7
942,582/6590
0.82 (0.71 to 0.95)
0.007181
27.60%
0.55 to 1.22
No
No
Yes
IV
Micronutrients
Riboflavin
Clasen 2020
3
39,789/1971
0.89 (0.70 to 1.13)
0.343247
0.00%
0.14 to 5.84
No
No
No
NS
Vitamin B6
Clasen 2020
5
164,883/2407
0.85 (0.70 to 1.04)
0.113403
0.00%
0.58 to 1.27
No
No
No
NS
Folate
Clasen 2020
6
136,319/3166
0.84 (0.69 to 1.03)
0.088191
6.00%
0.52 to 1.36
No
No
No
NS
Vitamin B12
Clasen 2020
3
127,390/1578
1.13 (0.88 to 1.46)
0.331795
0.00%
0.19 to 6.65
No
No
No
NS
Methionine
Clasen 2020
2
125,094/436
1.29 (0.90 to 1.85)
0.170519
0.00%
NA
NA
No
No
NS
Choline
Clasen 2020
2
125,094/436
0.87 (0.63 to 1.22)
0.433326
0.00%
NA
NA
No
No
NS
Betaine
Clasen 2020
2
125,094/436
1.01 (0.62 to 1.65)
0.962844
58.80%
NA
NA
No
No
NS
Vitamin C
Jia 2015
10
274,864/5182
0.77 (0.66 to 0.90)
0.000636
0.00%
0.54 to 1.10
No
No
No
III
Vitamin D
Wu 2020
6
187,560/NA
0.89 (0.71 to 1.11)
0.286865
36.50%
0.48 to 1.64
No
No
No
NS
Dietary nitrate
Xie 2016
3
NA/NA
0.78 (0.40 to 1.55)
0.482996
89.20%
0.0002 to 3013.70
No
No
NA
NS
Dietary nitrite
Xie 2016
2
NA/NA
0.99 (0.81 to 1.21)
0.892113
0.00%
NA
NA
No
No
NS
Vitamin E
Shen 2015
13
471,006/6944
0.81 (0.69 to 0.94)
0.006361
49.20%
0.52 to 1.26
No
No
No
IV
Alpha-carotene
WCRF 2013
4
284,501/787
0.96 (0.86 to 1.07)
0.448428
33.10%
0.32 to 2.86
No
No
No
NS
Beta-cryptoxanthin
WCRF 2013
4
284,501/787
0.97 (0.83 to 1.13)
0.700635
59.10%
0.19 to 4.91
No
No
Yes
NS
Lutein and zeaxanthin
WCRF 2013
4
284,501/787
0.99 (0.95 to 1.04)
0.827912
0.00%
0.71 to 1.40
Yes
No
No
NS
Lycopene
WCRF 2013
4
284,501/787
1.03 (0.73 to 1.47)
0.849859
5.90%
0.04 to 30.00
No
No
No
NS
Total calcium (food and supplements)
WCRF 2013
3
NA/1711
0.96 (0.94 to 0.99)
0.017337
0.00%
0.78 to 1.19
No
No
Yes
IV
Dietary calcium
WCRF 2013
3
NA/1574
0.98 (0.90 to 1.06)
0.614121
0.00%
0.45 to 2.12
No
No
No
NS
Calcium (supplements)
WCRF 2013
3
NA/1482
0.80 (0.64 to 0.99)
0.039569
0.00%
NA
NA
No
No
IV
*SHR derived from published meta-analysis, no recalculation; The association was not statistically significant after using the trim-and-fill method; #SHR was generated by combining the hazard ratios from the 2 meta-analyses; SHR summary hazard ratio; NA not available; NS nonsignificant; CI confidence intervals; PI prediction intervals; ASB artificially sweetened beverages; SSB sugar-sweetened beverages

Dietary patterns or dietary quality indices

Table 2 and Fig. 2 show the SHR, 95% CI, and level of evidence associating dietary patterns or dietary quality indices with the incidence of RCC. No dietary factors showed convincing or highly suggestive evidence of an association with RCC. There was 1 instance of weak evidence (class IV) that long-term adherence to a healthy dietary pattern 0.66 (0.51 to 0.85) was associated with a lower risk of developing RCC compared with nonadherence to a healthy dietary pattern. Similarly, there were 3 weak pieces of evidence (class IV) that chronic exposure to an unhealthy/Western pattern (1.54, 1.19 to 2.01), a high dietary inflammatory index (1.08, 1.03 to 1.13), or a hyperglycemic index (1.18, 1.02 to 1.37) was associated with a higher risk of developing RCC. Drinking pattern and glycemic load were not significantly associated with the incidence of RCC.

Foods, beverages, and alcoholic beverages

Table 2 and Fig. 3 show the SHR, 95% CI, and level of evidence for the association of foods with the incidence of RCC. No exposures for RCC showed convincing or highly suggestive evidence of an association. There was 1 case of suggestive evidence (class III) of an inverse association between increased vegetable (0.74, 0.63 to 0.86) intake and the incidence of RCC. There were 3 pieces of weak evidence (class IV) that increased intake of all meats (1.27, 1.08 to 1.49), processed meat (1.13, 1.01 to 1.26), and poultry (1.23, 1.02 to 1.47) were positively associated with the incidence of RCC. There was 1 instance of weak evidence (class IV) that increased intake of cruciferous vegetables (0.81, 0.71 to 0.92) were negatively associated with the incidence of RCC. Fish, fruits, fruit and non-starchy vegetables, non-starchy vegetables, tomatoes, and citrus fruit intake were not associated with the incidence of RCC. Seafood intake was not associated with RCC incidence. However, the level of evidence could not be assessed because data related to 95% PI, I2, small study effects, and excess significance bias could not be calculated.
Table 2 and Fig. 4 show the SHR, 95% CI, and level of evidence for the association of beverages with the incidence of RCC. No exposures for RCC showed convincing or highly suggestive evidence of an association. The intake of sweetened carbonated beverage, sweetened beverages, tea, and coffee was not associated with the incidence of RCC.
Table 2 and Fig. 5 show the SHR, 95% CI, and level of evidence for the association of alcoholic beverages with the incidence of RCC. No exposures for RCC showed convincing or highly suggestive evidence of an association. There were 2 pieces of weak evidence (class IV) that increased intake of wine (0.70, 0.52 to 0.94) and spirits (0.80, 0.64 to 0.99) was inversely associated with the incidence of RCC. Beer intake was not significantly associated with the incidence of RCC. Dose-response meta-analyses showed that light drinking (<12.5 g/d), moderate drinking (12.5–37.5 g/d), and heavy drinking (>37.5 g/d) were not significantly associated with the incidence of RCC. A high vs low meta-analysis also showed that any drinking was not significantly associated with the risk of developing RCC.

Macronutrients and micronutrients

Table 2 and Fig. 6 show the SHR, 95% CI, and level of evidence of the association of macronutrients with RCC incidence. No exposures for RCC showed convincing or highly suggestive evidence of an association. There was only 2 instance of weak evidence (class IV) showing that an inverse association between increased dietary fiber (0.82, 0.71 to 0.95) intake and the incidence of RCC and that increased animal protein (1.10, 1.00 to 1.20) intake was associated with the risk of RCC. Fruit fiber, vegetable fiber, cereal fiber, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, total protein, and plant protein were not significantly associated with the incidence of RCC. The remaining dietary factors (legume fiber, animal fat, plant fat, and cholesterol) could not be assessed for their level of evidence because the data related to 95% PI, I2, small study effects, and excess significance bias could not be calculated.
Table 2 and Fig. 7 show the SHR, 95% CI, and level of evidence of the association of micronutrients with the incidence of RCC. No exposures showed convincing or highly suggestive evidence of an association with RCC. There was 1 instance of suggestive evidence (class III) that increased intake of vitamin C (0.77, 0.66 to 0.90) was associated with a lower risk of RCC. There were 3 pieces of weak evidence (class IV) that increased intake of vitamin E (0.81, 0.69 to 0.94), total calcium from food and supplements (0.96, 0.94 to 0.99), and calcium from supplements (0.80, 0.64 to 0.99) was negatively related to the risk of RCC. The remaining dietary factors (riboflavin, folate, vitamin B12, methionine, betaine, vitamin D, dietary nitrate, choline, dietary nitrite, vitamin B6, alpha-carotene, beta-cryptoxanthin, lutein and zeaxanthin, lycopene, and dietary calcium) were not linked to the development of RCC.

Heterogeneity

The I2, τ2, and 95% PI are described in Additional file 1: Table S8 [1517, 6481, 87]. Of the 64 exposures, 8% (n=5) of I2, 8% (n=5) of τ2 and 30% (n=19) of 95% PI values could not be recalculated. In total, 67% (n=43) did not have high heterogeneity (I2<50%) for the following factors: healthy dietary pattern, unhealthy/Western pattern, drinking pattern, dietary inflammatory index, glycemic index, fish, all meat, processed meat, poultry, fruit and non-starchy vegetables, non-starchy vegetables, tomatoes, citrus fruit, coffee, beer, alcohol consumption (light), alcohol consumption (moderate), fruit fiber, cereal fiber, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, total protein, animal protein, plant protein, dietary fiber, riboflavin, vitamin B6, folate, vitamin B12, methionine, choline, vitamin C, vitamin D, dietary nitrite, vitamin E, alpha-carotene, lutein and zeaxanthin, dietary lycopene, total calcium (food and supplements), dietary calcium, and calcium (supplements). For 95% PI, all exposures included null values.

Publication bias and small study effects

Of the 59 contour-enhanced funnel plots, 29% (n=17) included 10 or more individual studies, 31% (n=18) included between 5 and 10 individual studies, and 31% (n=18) included fewer than 3 individual studies. The contour-enhanced funnel plots corresponding to each exposure are shown (see Additional file 2: Figs. S1–S10). Small study effects for five dietary factors, namely, vegetables, red meat, fruit and non-starchy vegetables, vegetable fiber, and lutein and zeaxanthin (Egger’s test; p=0.049, p=0.003, p=0.079, p=0.096, and p=0.093, respectively) were shown in Additional file 1: Table S8 and Additional file 2: Figs. S2B, S2D, S3C, S6B, and S10C. Using the trim-and-fill technique, we found that for vegetables, 2 missing studies were added, and the association (0.77, 0.67 to 0.88) was weaker than the previous association (0.74, 0.63 to 0.86) (see Additional file 2: Fig. S11A); for red meat, 8 missing studies were added, and the association (1.10, 0.93 to 1.30) was not statistically significant as was the previous association (1.40, 1.15 to 1.70) (see Additional file 2: Fig. S11B); for vegetable fiber and fruit and non-starchy vegetables, no missing studies were added to the plot (see Additional file 2: Fig. S11C and S11D); for lutein and zeaxanthin, 2 missing studies were added, and they are still not significantly associated with the risk of RCC (see Additional file 2: Fig. S11E).

Subgroup analysis and sensitivity analysis

The results of the subgroup analyses of the associations between various dietary factors and the risk of RCC by study design are shown in Additional file 1: Table S9. In full analysis, increased intake of vegetables (class III) and dietary fiber (class IV) was significantly associated with a lower risk of RCC and was also observed to be significantly associated in both cohort and case-control studies. In the case-control study, the evidence level for vegetables increased from class III to class II due to a decrease in p value from 7.3×10-5 to 9.18×10-10 and the evidence level for dietary fiber also increased from class IV to class III due to a decrease in p value from 7.18×10-3 to 4×10-4. Nine instances of evidence with a statistically significant difference were observed for nonsignificant results in the cohort study, but significant results in the case-control study (healthy dietary pattern, unhealthy/Western pattern, dietary inflammatory index, glycemic index, red meat, poultry, cruciferous vegetables, vitamin C, vitamin E). For processed meat, a weak level of evidence in full analysis was found, whereas the results were nonsignificant in both cohort and case-control, respectively.
The results of the subgroup analyses of the associations between various dietary factors and the risk of RCC by region are shown in Additional file 1: Table S10. Long-term adherence to a healthy dietary pattern was significantly associated with a low risk of RCC in America, but not in Europe (class III, 0.62, 0.51 to 0.76). Similarly, long-term adherence to an unhealthy dietary pattern (class III, 1.61, 1.33 to 1.95) and increased intake of red meat (class III, 1.61, 1.24 to 2.10) and processed meat (class III, 1.19, 1.11 to 1.28) were significantly associated with a high risk of RCC in America, but not in Europe and Asia. Increased intake of all meat (class III, 1.27, 1.13 to 1.43) was significantly associated with a high risk of RCC in North America, however, increased intake of cruciferous vegetables (class II, 0.78, 0.70 to 0.86) and dietary fiber (class III, 0.75, 0.67 to 0.85) was significantly associated with a low risk of RCC. Increased intake of any alcohol (class III, 0.89, 0.83 to 0.94) and moderate drinking (class I, 0.77, 0.70 to 0.84) were significantly associated with a low risk of developing RCC in Europe and North America. Increased vegetable (class III, 0.70, 0.60 to 0.81) intake is significantly associated with a lower risk of RCC in Europe.
Only vegetables maintained the same level of evidence after removing small-sized studies and low-quality studies (see Additional file 1: Table S11). After removing the small-sized studies, the level of evidence for vitamin C decreased from suggestive evidence (class III) to weak evidence (class IV) due to an increase in p value from 6.63×10-4 to 9.71×10-3.

Discussion

Main findings

We conducted an umbrella review of the effect of diet, including dietary patterns, dietary quality indices, foods, beverages (including alcohol), and nutrients, rather than a specific dietary factor, on the incidence of RCC. In our study, the evidence associating dietary factors with the incidence of RCC from available meta-analyses was summarized, and the strength and validity of this evidence were evaluated.
There were 22 published meta-analyses included, with a total of 64 SHRs for various dietary factors and RCC risk. No meta-analyses were rated as high in terms of methodological quality, and approximately 1/3 were rated as moderate. Two pieces of suggestive evidence (class III) suggested that increasing vegetable and vitamin C intake might have a negative correlation with the incidence of RCC. Eight pieces of weak evidence (class IV) showed that adhering to a healthy dietary pattern was associated with a lower risk of RCC and that increased intake of cruciferous vegetables, wine, spirits, dietary fiber, vitamin E, total calcium (foods and supplements), and calcium (supplements) were negatively associated with the incidence of RCC. Seven pieces of weak evidence (class IV) showed that long-termed unhealthy pattern is positively linked with RCC incidence and that a 1-unit increase in the dietary inflammatory index, hyperglycemic index, and increased intake of all meat, processed meat, poultry, and animal protein was associated with a higher risk of RCC. The remaining dietary factors were not associated with RCC incidence.
In subgroup analysis on regions, a piece of convincing evidence (class I) suggested that moderate drinking had a positive association with a low risk of developing RCC in Europe and North America. A piece of suggestive evidence (class III) suggested that increased consumption of any alcohol was positively related to a low risk of developing RCC in Europe and North America. A piece of highly suggestive evidence (class II) suggested that increased intake of cruciferous vegetables was positively linked with a low risk of RCC in North America. Two pieces of suggestive evidence (class III) suggested that increased consumption of all meat was positively related to a high risk of RCC and that increased consumption of dietary fiber was positively linked with a low risk of RCC in North America. Four pieces of suggestive evidence (class III) suggested that a healthy dietary pattern might have a negative correlation with the incidence of RCC and that an unhealthy dietary pattern and increased intake of red meat and processed meat were positively associated with a high risk of RCC in America. Two pieces of suggestive evidence (class III) suggested that increased intake of vegetables and Vitamin C is significantly associated with a lower risk of RCC in Europe.

Possible explanations and comparison with other studies

Increasing vegetable consumption was found to be inversely related to RCC risk in our study. A meta-analysis conducted by Zhang et al. found that the protective effect of vegetables was diminished after adjustment for body mass index [80], implying that obesity might be an important intermediate mechanism between vegetable consumption and the incidence of RCC. Obesity has been acknowledged by the guidelines of the European Association of Urology as a risk factor for RCC [146], which might be related to the inverse association between vegetables and obesity [147151]. A randomized double-blind controlled trial in Japan showed that increasing the consumption of vegetables rich in carotenoids reduced visceral obesity in Japanese men [151]. Dreher et al. conducted a randomized controlled trial and prospective trial on the effect of vegetable consumption on weight loss in females and concluded that increased vegetable intake was a major factor in weight loss in women [150]. Moreover, a diet low in vegetables contributes to obesity and a pro-inflammatory adipokine profile [149]. A healthy pattern consisting of vegetables, fruits, juices, and exercise was found to be inversely associated with abdominal obesity [148].
Phytochemical extracts and compounds secreted from vegetables, such as isothiocyanates (ITC), sulforaphane (SFN), and indole-3-carbinol (I3C) [152], have strong antioxidant and antiproliferative activity [153, 154] and may be the main anticancer components [155]. Cytochrome P450 (CYP) enzymes are biotransformation enzymes whose reduced activity inhibits cancer progression [156]. SFN can inhibit the activity of CYP3A4 in human hepatocytes [157]. In cultured human cells, ITC was observed to have potent antiproliferative activity [158161]. In addition, ITC, indole, and vegetable-secreted compounds play an important role in blocking carcinogen-activating enzymes, triggering carcinogen-detoxifying enzymes, increasing apoptosis, and halting cell cycle progression [152, 154, 157, 162, 163]. Notably, there is potential for publication bias in the meta-analysis associating vegetable consumption with RCC incidence in this study. The association was found to be attenuated after using the trim-and-fill technique, implying that the results of this meta-analysis were exaggerated. However, the association remained statistically significant after imputing 2 additional studies in the plot by using the trim-and-fill method. To verify the robustness of the results, we performed sensitivity analyses by excluding small-sized studies and low-quality studies. Sensitivity analyses indicated that no significant variation in adjusted SHR and the level of evidence remains at class III, confirming the stability of present results.
Our study found that increased vitamin C intake was negatively associated with the incidence of RCC. Extensive cytosine methylation abnormalities are associated with RCC tumorigenesis, and 5-hydroxymethylcytosine (5hmC) deficiency is associated with the recurrence of RCC [164]. 5hmC deficiency can decrease the survival of RCC patients [165]. 5-methylcytosine (5mC) can be transformed to 5hmC with the intervention of ten-eleven translocation (TET) enzymes [166]. However, TET enzymes are frequently mutated [167]. A decrease in TET enzyme activity would lead to a decrease in 5hmC levels and thus potentially carcinogenesis [168171]. A decrease in TET enzyme activity might be associated with a deficiency of the cofactor (vitamin C) of the TET gene. In addition, vitamin C, an important antioxidant, is commonly used to reduce carcinoma risk [72]. Experimental studies have revealed that 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins play important oxidative roles in human RCC [172, 173]. However, vitamin C may contribute significantly to the antioxidant effect and increase 5hmC levels. Notably, the sensitivity analysis suggested vitamin C downgraded to a weak (class IV) level of evidence by excluding small-sized studies. Therefore, we assume that there might be an exaggerated relationship between vitamin C and a low risk of developing RCC.
Our study confirmed a false association between red meat intake and the risk of RCC [17]. The SHR (1.40,1.15 to 1.70) for red meat intake and the incidence of RCC was obtained by combining hazard ratios from 19 individual studies, implying that an increased ingestion of red meat was significantly correlated with RCC risk. Based on the p value for Egger’s test (p=0.003) and asymmetric contour-enhanced funnel plots (see Additional file 1: Table S8 and Additional file 2: Fig. S2D), we found that 8 missing studies were added to the plot for red meat by using the trim-and-fill technique, and the association (1.10, 0.93 to 1.30) was no longer statistically significant. Moreover, the association initially rated as class III was no longer considered suggestive evidence and was downgraded to class V (nonsignificant). However, heterogeneity between regions or populations is reasonable to suspect because of different dietary patterns across populations. So we performed subgroup analysis by regions. We found that healthy dietary pattern was inversely associated with the risk of RCC and unhealthy/Western dietary pattern had a positive correlation with RCC risk in America, but not in Europe or Asia. This unhealthy/Western dietary pattern is often characterized by a high intake of red meat and processed meat. A prospective trial based on a large USA cohort identifies cooking compounds, particularly benzo(a)pyrene (a polycyclic aromatic hydrocarbon) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (a heterocyclic amines), as a possible mechanism for the association of increased red meat intake with high risk of RCC [174]. The healthy dietary pattern is characterized by a higher intake of vegetables and dietary fiber, especially cruciferous vegetables. Cruciferous vegetables are rich in ITC, SFN, and I3C [152], which may have strong antioxidant [153, 154] and anticancer effects [155].
Our study found 2 pieces of convincing and suggestive evidence that moderate drinking (class I) and any drinking (class III) is more likely to be associated with a lower risk of developing RCC in Europeans and Americans compared to Asians, and a nonsignificant result that heavy drinking is not associated with RCC risk, which is consistent with what Bellocco and colleagues found [82]. However, they reported a negative association between light alcohol consumption and the risk of RCC, which is inconsistent with our results. The inclusion of different individual studies might be one of the reasons for the inconsistency. The Bellocco meta-analysis included case-control studies and cohort studies on the association between alcohol drinking and RCC risk, whereas we included only prospective cohort studies. Furthermore, their meta-analysis did not include these three new individual studies associating alcohol drinking with RCC [175177]. In addition, differences in the extent to which people in different regions and races are affected by alcohol may also contribute to the inconsistency.
We found a total of 18 dietary factors associated with the risk of RCC. Some results must be interpreted with caution. In case of processed meat, evidence was significant in the full analysis, whereas the results were nonsignificant in both cohort and case-control, respectively. Different study designs and the heterogeneity between studies may be one of the reasons to explain this result. To conclude, because the outcomes were nonsignificant in both study designs, the evidence of processed meat could overestimate the true effect and could thus be reconsidered. Moreover, we found that cohort studies tended to show nonsignificant results, while case-control studies tended to show significant results and higher levels of evidence, such as the 9 associations between dietary factors with RCC risk (healthy dietary pattern, unhealthy/Western pattern, dietary inflammatory index, glycemic index, red meat, poultry, cruciferous vegetables, vitamin C, vitamin E). So meta-analysis of case-control studies may have spurious associations or even seriously drive the magnitudes of the associations.
There has been much interest in the topic of preventing noncommunicable diseases (e.g., cancer) by modifying dietary habits or patterns. To date, a large number of publications have reported correlations between diet and RCC incidence, including individual studies and SRoMAs, providing a large body of evidence. However, most current guidelines, including those of the European Society for Medical Oncology, the American Urological Association, and the National Comprehensive Cancer Network, do not provide recommendations on how to prevent the incidence of RCC by modifying dietary habits or patterns. Moreover, the European Association of Urology guidelines only briefly mention that specific dietary habits may influence the incidence of RCC, but the findings were inconclusive [146]. Although the highest level of evidence derived from the present umbrella review was suggestive evidence (class III), it is the best evidence available and fills a gap in the guidelines. In our review, all presently available evidence from SRoMAs on dietary factors and the incidence of RCC was synthesized, and the level of evidence was appraised. From the results of the study, it is clear that increased ingestion of vegetables and vitamin C has a negative association with the incidence of RCC. Although the 2 pieces of evidence were suggestive (class III), both exposures (vegetables and vitamin C) were associated with RCC incidence (p<10 −3), there was no high heterogeneity between studies, and there was no excess significance bias. Notably, both 95% PIs for exposures included null values, implying that in some cases, the effect of exposure on outcome may be nonexistent. As a result, the findings should be interpreted with caution. In addition, our study supports the statement that moderate alcohol consumption is protective, as mentioned in the European Association of Urology guidelines [146], but only for Europeans and North Americans.
In a previous study, Papadimitriou and colleagues performed an umbrella review of evidence on the association of diet with the risk of 11 cancers (including RCC) [178]. The present study differs from their study in the following ways: (1) their literature was searched through March 2013, whereas ours was searched through April 2021; (2) the databases searched were not identical; (3) the present study included more recent meta-analyses and included more exposures (64 v 24), such as dietary inflammatory index, glycemic index, vitamin D, and riboflavin; (4) their study did not exclude overlapping SRoMAs and therefore, was likely to include duplicate individual studies, resulting in biased results and associations [46, 47]. In contrast, our study used a validated CCA tool to evaluate the degree of overlap of overlapping meta-analyses and selected the highest quality meta-analyses available; (5) their study included 274 individual studies without excluding overlapping meta-analyses, while our study included 502 individual studies after excluding overlapping meta-analyses; (6) their study did not use relevant quality appraisal instruments to evaluate the methodological quality of the included SRoMAs, whereas our study used AMSTAR 2 to address this issue; and (7) our study included pooled studies in addition to cohort studies and case-control studies. Thus, our study differs from the previous study in many ways but is similar in terms of the section on dietary fiber.

Strengths and limitations

The present study had many strengths. Our study synthesized evidence from the existing available published meta-analyses. The AMSTAR 2 instrument was employed to assess the methodological quality of the included meta-analyses. We employed credibility assessment criteria by conducting a large number of statistical tests to classify the level of evidence, as in previous umbrella reviews [23, 24, 27, 29, 30]. CCA combined with AMSTAR 2 was used to quantify the degree of overlap of overlapping meta-analyses and to select the highest quality and most recent meta-analysis, thus avoiding double counting and selection bias. We used not only contour-enhanced funnel plots but also a combination of Egger’s regression asymmetry tests and the trim-and-fill technique to determine whether the asymmetry of the plots was precipitated by publication bias and to assess whether the included meta-analyses reported exaggerated results.
Some limitations exist in the present study. Missing data in the included meta-analyses prevented us from calculating some metrics, such as small study effects, I2, τ2, 95% PI, and excess significance bias. Therefore, the level of this part of the evidence could not be evaluated. In addition, we were unable to assess whether there was publication bias in this meta-analysis because some of the meta-analyses included too few individual studies, which prevented us from performing Egger’s test [179]. During our literature screening process, we found some reviews associating some dietary factors with RCC. However, our umbrella review did not include these publications because they were not SRoMAs (i.e., narrative reviews or synthesis of reviews). Therefore, the present umbrella review did not include a small proportion of the evidence associating a particular dietary exposure with RCC incidence. For example, Jeyaraman et al. found no significant association between dairy intake and the incidence of RCC [103], whereas a narrative review by Key et al. reported that increased dairy ingestion increased the RCC risk [106]. Limited data availability made it impossible to assess the exact association between dairy products and the incidence of RCC. We did not include systematic reviews without meta-analyses, which may lead to bias. This may limit the generalizability of our results if the systematic reviews without meta-analysis or non-SRoMAs contain issues that were not included in the umbrella review [90, 93, 104106, 110, 125, 134, 180]. In addition, from the search date to the publication of the results of this study, new SRoMAs showing an association of some dietary factors with RCC may have been published online.
Fundamentally, since the data in our study come from observational studies, confounding factors are inevitable [181]. Recall bias and selection bias are more prominent in case-control studies than in cohort studies because lifestyle and dietary factors are identified following a cancer diagnosis in case-control studies. In addition, some of the individual studies might have unknown confounding factors. The meta-analyses included in this umbrella review, however, were corrected as much as possible for confounding factors such as sex, age, body mass index, and smoking. More prospective research, such as cohort studies or randomized controlled trials, is needed in the future because residual confounding factors could not be totally ruled out.
Due to the rigorous items of the AMSTAR 2 instrument, the methodological quality of many of the meta-analyses was graded as low or critically low. However, inadequate reporting of meta-analyses rather than methodological flaws can also lead to a downgrading of methodological quality. Since our study included SRoMAs, the quality of the individual studies was not assessed. This should be the work of the investigators of the SRoMAs. Gray literature was not considered in this study, which may lead to some bias. Umbrella review evidence is also subject to residual confounding factors due to the type of original studies included, which were mostly observational in nature. The evidence associating legume fiber with RCC came from only one individual study [70], and the number of reported events was low, which might lead to inaccurate results.
Heterogeneity in this study may arise from the study design, region, control selection, sex, and measurement methods. For example, the meta-analyses included in this study included case-control studies, cohort studies, and pooled studies. In addition, heterogeneity in this study may stem from the definitions of different comparator groups, as different studies set specific comparator groups, such as tertiles and quartiles of vegetable intake levels.
Regarding publication bias, according to Egger’s test and contour-enhanced funnel plots, only 5 exposures in this study were potentially subject to publication bias, but 31% of the meta-analyses contained 5 to 10 individual studies, and 31% included no more than 3 individual studies (see Additional file 2: Figs. S1–S10), which implies that the results may be unreliable. Therefore, more studies of the associations of dietary factors with RCC risk are needed in the future. For example, using the trim-and-fill method, our study found that 2 additional studies on vegetable intake are needed on the right-hand side, and 8 additional studies on red meat intake are needed on the left-hand side. This is especially true for other meta-analyses that included even smaller numbers of individual studies.

Future research outlook

To obtain more high-quality evidence on dietary factors and the risk of RCC, future studies should consider the following aspects. To reduce bias and confounding factors, studies with high-quality study designs, such as prospective cohort studies or randomized controlled trials, are recommended. Efforts are being made to conduct more research on the biological mechanisms associating specific dietary factors with RCC risk. Guidelines should be followed for conducting SRoMAs to improve methodological quality and to obtain high-quality evidence, such as identifying the protocol before performing the systematic review, registering the protocol on a website (e.g., PROSPERO), conducting a comprehensive search (including unpublished data and gray literature), providing a summary of excluded publications, giving reasons for exclusion, and selecting an appropriate quality assessment instrument to assess the risk of bias for each included individual study. Considering the potential for food interactions and the effect of confounding factors, it is recommended that studies on the effect of different dietary patterns on the incidence of RCC be conducted in the context of specific scenarios whenever possible.

Conclusions

Overall, although a large number of SRoMAs have been published on the associations of diet with RCC incidence, none of the evidence has been classified as classes I–II in overall analysis. Increased intake of vegetables and vitamin C is inversely associated with the incidence of RCC, but the level of the evidence is class III. Moderate drinking may be beneficial for Europeans and North Americans, and cruciferous vegetables may be beneficial to North Americans. More research is needed in the future.

Acknowledgements

We are highly indebted to Xingxia Zhang for providing methodological guidance. Many thanks are expressed to the American Journal Experts for editing our manuscript.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary Information

Additional file 2: Figure S1. Contour-enhanced funnel plots associating dietary patterns or diet quality indices with RCC incidence: A) healthy dietary pattern, B) unhealthy/Western pattern, C) drinking pattern, D) dietary inflammatory index, E) glycemic index, and F) glycemic load. Figure S2. Contour-enhanced funnel plots associating foods with RCC incidence: A) fish, B) vegetables, C) fruits, D) red meat, E) processed meat, and F) cruciferous vegetables. Figure S3. Contour-enhanced funnel plots associating foods with RCC incidence: A) poultry, B) all meat, C) fruit and non-starchy vegetables, D) non-starchy vegetables, E) tomatoes, and F) citrus fruit. Figure S4. Contour-enhanced funnel plots associating beverages with RCC incidence: A) sweet beverages (including artificially sweetened beverages and sugar-sweetened beverages), B) tea, C) coffee, and D) sweetened carbonated beverage. Figure S5. Contour-enhanced funnel plots associating alcoholic beverages with RCC incidence: A) beer, B) wine, C) spirits, D) alcohol (light), E) alcohol (moderate), F) alcohol (heavy), and G) alcohol (any). Figure S6. Contour-enhanced funnel plots associating macronutrients with RCC incidence: A) fruit fiber, B) vegetable fiber, C) cereal fiber, D) dietary fiber, E) Total fat, and F) saturated fat. Figure S7. Contour-enhanced funnel plots associating macronutrients with RCC incidence: A) monounsaturated fat, B) polyunsaturated fat, C) total protein, D) animal protein, and E) plant protein. Figure S8. Contour-enhanced funnel plots associating micronutrients with RCC incidence: A) riboflavin, B) vitamin B6, C) folate, D) vitamin B12, E) methionine, and F) choline. Figure S9. Contour-enhanced funnel plots associating micronutrients with RCC incidence: A) betaine, B) vitamin C, C) vitamin D, D) dietary nitrate, E) dietary nitrite, and F) vitamin E. Figure S10. Contour-enhanced funnel plots associating micronutrients with RCC incidence: A) alpha-carotene, B) beta-cryptoxanthin, C) lutein and zeaxanthin, D) dietary lycopene, E) total calcium (food and supplements), F) dietary calcium, and G) Calcium (supplements). Figure S11. After using the trim-and-fill method, contour-enhanced funnel plots for the association between A) vegetables, B) red meat, C) vegetable fiber, D) fruit and non-starchy vegetables, and E) lutein and zeaxanthin and the incidence of renal cell carcinoma were generated.
Literatur
1.
Zurück zum Zitat Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74–84.PubMedCrossRef Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74–84.PubMedCrossRef
2.
Zurück zum Zitat Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.PubMedCrossRef Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.PubMedCrossRef
3.
Zurück zum Zitat Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, et al. NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw. 2009;7(6):618–30.PubMedCrossRef Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, et al. NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw. 2009;7(6):618–30.PubMedCrossRef
4.
5.
Zurück zum Zitat Islami F, Ward EM, Sung H, Cronin KA, Tangka FKL, Sherman RL, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics. J Natl Cancer Inst. 2021. Islami F, Ward EM, Sung H, Cronin KA, Tangka FKL, Sherman RL, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics. J Natl Cancer Inst. 2021.
6.
Zurück zum Zitat Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef
7.
Zurück zum Zitat Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.PubMedCrossRef Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.PubMedCrossRef
8.
Zurück zum Zitat Maroun R, Fleury L, Nachbaur G, Maunoury F, Vanhille JL, Durand-Zaleski I. Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance database. Curr Med Res Opin. 2017;33(10):1755–62.PubMedCrossRef Maroun R, Fleury L, Nachbaur G, Maunoury F, Vanhille JL, Durand-Zaleski I. Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance database. Curr Med Res Opin. 2017;33(10):1755–62.PubMedCrossRef
9.
Zurück zum Zitat Tahbaz R, Schmid M, Merseburger AS. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol. 2018;28(1):62–79.PubMedCrossRef Tahbaz R, Schmid M, Merseburger AS. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol. 2018;28(1):62–79.PubMedCrossRef
10.
Zurück zum Zitat Schouten LJ, van Dijk BA, Oosterwijk E, van Engeland M. Hulsbergen-van de Kaa CA, Kiemeney LA, et al. Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3543–50.PubMedCrossRef Schouten LJ, van Dijk BA, Oosterwijk E, van Engeland M. Hulsbergen-van de Kaa CA, Kiemeney LA, et al. Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3543–50.PubMedCrossRef
11.
Zurück zum Zitat Karami S, Brennan P, Navratilova M, Mates D, Zaridze D, Janout V, et al. Vitamin D pathway genes, diet, and risk of renal cell carcinoma. Int J Endocrinol. 2010;2010:879362.PubMedCrossRef Karami S, Brennan P, Navratilova M, Mates D, Zaridze D, Janout V, et al. Vitamin D pathway genes, diet, and risk of renal cell carcinoma. Int J Endocrinol. 2010;2010:879362.PubMedCrossRef
12.
Zurück zum Zitat Rhee J, Loftfield E. Freedman ND. Sinha R, Purdue MP. Coffee consumption and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Int J Epidemiol: Liao LM; 2021. Rhee J, Loftfield E. Freedman ND. Sinha R, Purdue MP. Coffee consumption and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Int J Epidemiol: Liao LM; 2021.
13.
Zurück zum Zitat van de Pol JAA, George L, van den Brandt PA, Baldewijns M, Schouten LJ. Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study. Int J Cancer. 2021;148(1):67–76.PubMedCrossRef van de Pol JAA, George L, van den Brandt PA, Baldewijns M, Schouten LJ. Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study. Int J Cancer. 2021;148(1):67–76.PubMedCrossRef
14.
Zurück zum Zitat Daniel CR, Park Y, Chow WH, Graubard BI, Hollenbeck AR, Sinha R. Intake of fiber and fiber-rich plant foods is associated with a lower risk of renal cell carcinoma in a large US cohort. Am J Clin Nutr. 2013;97(5):1036–43.PubMedPubMedCentralCrossRef Daniel CR, Park Y, Chow WH, Graubard BI, Hollenbeck AR, Sinha R. Intake of fiber and fiber-rich plant foods is associated with a lower risk of renal cell carcinoma in a large US cohort. Am J Clin Nutr. 2013;97(5):1036–43.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Faramawi MF, Johnson E, Fry MW, Sall M, Zhou Y. Consumption of different types of meat and the risk of renal cancer: meta-analysis of case-control studies. Cancer Causes Control. 2007;18(2):125–33.PubMedCrossRef Faramawi MF, Johnson E, Fry MW, Sall M, Zhou Y. Consumption of different types of meat and the risk of renal cancer: meta-analysis of case-control studies. Cancer Causes Control. 2007;18(2):125–33.PubMedCrossRef
16.
Zurück zum Zitat Lee JE, Spiegelman D, Hunter DJ, Albanes D, Bernstein L, van den Brandt PA, et al. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst. 2008;100(23):1695–706.PubMedPubMedCentralCrossRef Lee JE, Spiegelman D, Hunter DJ, Albanes D, Bernstein L, van den Brandt PA, et al. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst. 2008;100(23):1695–706.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Zhang S, Wang Q, He J. Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies. Oncotarget. 2017;8(44):77942–56.PubMedPubMedCentralCrossRef Zhang S, Wang Q, He J. Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies. Oncotarget. 2017;8(44):77942–56.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Alexander DD, Cushing CA. Quantitative assessment of red meat or processed meat consumption and kidney cancer. Cancer Detect Prev. 2009;32(5-6):340–51.PubMedCrossRef Alexander DD, Cushing CA. Quantitative assessment of red meat or processed meat consumption and kidney cancer. Cancer Detect Prev. 2009;32(5-6):340–51.PubMedCrossRef
19.
Zurück zum Zitat Ioannidis JP. Why most discovered true associations are inflated. Epidemiology. 2008;19(5):640–8.PubMedCrossRef Ioannidis JP. Why most discovered true associations are inflated. Epidemiology. 2008;19(5):640–8.PubMedCrossRef
21.
Zurück zum Zitat Dwan K, Gamble C, Williamson PR, Kirkham JJ. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS One. 2013;8(7):e66844.PubMedPubMedCentralCrossRef Dwan K, Gamble C, Williamson PR, Kirkham JJ. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS One. 2013;8(7):e66844.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst. 2008;100(14):988–95.PubMedPubMedCentralCrossRef Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst. 2008;100(14):988–95.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, et al. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry. 2018;17(1):49–66.PubMedPubMedCentralCrossRef Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, et al. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry. 2018;17(1):49–66.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Howes OD, Whitehurst T, Shatalina E, Townsend L, Onwordi EC, Mak TLA, et al. The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis. World Psychiatry. 2021;20(1):75–95.PubMedPubMedCentralCrossRef Howes OD, Whitehurst T, Shatalina E, Townsend L, Onwordi EC, Mak TLA, et al. The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis. World Psychiatry. 2021;20(1):75–95.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14(3):263–73.PubMedCrossRef Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14(3):263–73.PubMedCrossRef
26.
Zurück zum Zitat Okoth K, Chandan JS, Marshall T, Thangaratinam S, Thomas GN, Nirantharakumar K, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. Bmj. 2020;371:m3502.PubMedPubMedCentralCrossRef Okoth K, Chandan JS, Marshall T, Thangaratinam S, Thomas GN, Nirantharakumar K, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. Bmj. 2020;371:m3502.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis JP, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. Bmj. 2017;357:j2376.PubMedPubMedCentralCrossRef Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis JP, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. Bmj. 2017;357:j2376.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Neuenschwander M, Ballon A, Weber KS, Norat T, Aune D, Schwingshackl L, et al. Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. Bmj. 2019;366:l2368.PubMedPubMedCentralCrossRef Neuenschwander M, Ballon A, Weber KS, Norat T, Aune D, Schwingshackl L, et al. Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. Bmj. 2019;366:l2368.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. Bmj. 2017;356:j477.PubMedPubMedCentralCrossRef Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. Bmj. 2017;356:j477.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Mitra A, et al. Obesity and gynaecological and obstetric conditions: umbrella review of the literature. Bmj. 2017;359:j4511.PubMedPubMedCentralCrossRef Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Mitra A, et al. Obesity and gynaecological and obstetric conditions: umbrella review of the literature. Bmj. 2017;359:j4511.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. Cmaj. 2009;181(8):488–93.PubMedPubMedCentralCrossRef Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. Cmaj. 2009;181(8):488–93.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Markozannes G, Tzoulaki I, Karli D, Evangelou E, Ntzani E, Gunter MJ, et al. Diet, body size, physical activity and risk of prostate cancer: an umbrella review of the evidence. Eur J Cancer. 2016;69:61–9.PubMedCrossRef Markozannes G, Tzoulaki I, Karli D, Evangelou E, Ntzani E, Gunter MJ, et al. Diet, body size, physical activity and risk of prostate cancer: an umbrella review of the evidence. Eur J Cancer. 2016;69:61–9.PubMedCrossRef
33.
Zurück zum Zitat Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40.PubMedCrossRef Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40.PubMedCrossRef
34.
Zurück zum Zitat Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.PubMedPubMedCentralCrossRef Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Aromataris E, Fernandez R, Godfrey C, Holly C, Khalil H, Tungpunkom P. Methodology for jbi umbrella reviews. The Joanna Briggs Institute Reviewers Manual 2014: Joanna Briggs Institute; 2014. p. 5-34. Aromataris E, Fernandez R, Godfrey C, Holly C, Khalil H, Tungpunkom P. Methodology for jbi umbrella reviews. The Joanna Briggs Institute Reviewers Manual 2014: Joanna Briggs Institute; 2014. p. 5-34.
36.
Zurück zum Zitat Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Bmj. 2017;358:j4008.PubMedPubMedCentralCrossRef Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Bmj. 2017;358:j4008.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat AMSTAR. Assessing the methodological quality of systematic reviews. [Available from: https:/ /amstar.ca/Amstar_Checklist.php]. AMSTAR. Assessing the methodological quality of systematic reviews. [Available from: https:/ /amstar.ca/Amstar_Checklist.php].
38.
Zurück zum Zitat Lorenz RC, Matthias K, Pieper D, Wegewitz U, Morche J, Nocon M, et al. A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool. J Clin Epidemiol. 2019;114:133–40.PubMedCrossRef Lorenz RC, Matthias K, Pieper D, Wegewitz U, Morche J, Nocon M, et al. A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool. J Clin Epidemiol. 2019;114:133–40.PubMedCrossRef
39.
Zurück zum Zitat Créquit P, Trinquart L, Yavchitz A, Ravaud P. Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer. BMC Med. 2016;14:8.PubMedPubMedCentralCrossRef Créquit P, Trinquart L, Yavchitz A, Ravaud P. Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer. BMC Med. 2016;14:8.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, et al. Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol. 2017;91:23–30.PubMedCrossRef Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, et al. Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol. 2017;91:23–30.PubMedCrossRef
41.
Zurück zum Zitat Garner P, Hopewell S, Chandler J, MacLehose H, Schünemann HJ, Akl EA, et al. When and how to update systematic reviews: consensus and checklist. Bmj. 2016;354:i3507.PubMedPubMedCentralCrossRef Garner P, Hopewell S, Chandler J, MacLehose H, Schünemann HJ, Akl EA, et al. When and how to update systematic reviews: consensus and checklist. Bmj. 2016;354:i3507.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Shojania KG, Sampson M, Ansari MT, Ji J, Doucette S, Moher D. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med. 2007;147(4):224–33.PubMedCrossRef Shojania KG, Sampson M, Ansari MT, Ji J, Doucette S, Moher D. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med. 2007;147(4):224–33.PubMedCrossRef
43.
Zurück zum Zitat Pieper D, Antoine SL, Mathes T, Neugebauer EA, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014;67(4):368–75.PubMedCrossRef Pieper D, Antoine SL, Mathes T, Neugebauer EA, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014;67(4):368–75.PubMedCrossRef
44.
Zurück zum Zitat Bougioukas KI, Liakos A, Tsapas A, Ntzani E, Haidich AB. Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms. J Clin Epidemiol. 2018;93:9–24.PubMedCrossRef Bougioukas KI, Liakos A, Tsapas A, Ntzani E, Haidich AB. Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms. J Clin Epidemiol. 2018;93:9–24.PubMedCrossRef
45.
46.
Zurück zum Zitat Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11(1):15.PubMedPubMedCentralCrossRef Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11(1):15.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Pollock M, Fernandes RM, Newton AS, Scott SD, Hartling L. A decision tool to help researchers make decisions about including systematic reviews in overviews of reviews of healthcare interventions. Syst Rev. 2019;8(1):29.PubMedPubMedCentralCrossRef Pollock M, Fernandes RM, Newton AS, Scott SD, Hartling L. A decision tool to help researchers make decisions about including systematic reviews in overviews of reviews of healthcare interventions. Syst Rev. 2019;8(1):29.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Pollock M, Fernandes RM, Newton AS, Scott SD, Hartling L. The impact of different inclusion decisions on the comprehensiveness and complexity of overviews of reviews of healthcare interventions. Syst Rev. 2019;8(1):18.PubMedPubMedCentralCrossRef Pollock M, Fernandes RM, Newton AS, Scott SD, Hartling L. The impact of different inclusion decisions on the comprehensiveness and complexity of overviews of reviews of healthcare interventions. Syst Rev. 2019;8(1):18.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Sidik K, Jonkman JN. A simple confidence interval for meta-analysis. Stat Med. 2002;21(21):3153–9.PubMedCrossRef Sidik K, Jonkman JN. A simple confidence interval for meta-analysis. Stat Med. 2002;21(21):3153–9.PubMedCrossRef
51.
Zurück zum Zitat Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions: John Wiley & Sons; 2019.CrossRef Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions: John Wiley & Sons; 2019.CrossRef
52.
Zurück zum Zitat Higgins J, Green S, Collaboration C. Cochrane handbook for systematic reviews of interventions: Wiley-Blackwell; 2008.CrossRef Higgins J, Green S, Collaboration C. Cochrane handbook for systematic reviews of interventions: Wiley-Blackwell; 2008.CrossRef
53.
Zurück zum Zitat Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.PubMedCrossRef Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.PubMedCrossRef
55.
Zurück zum Zitat Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. Bmj. 2011;342:d549.PubMedCrossRef Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. Bmj. 2011;342:d549.PubMedCrossRef
56.
Zurück zum Zitat Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991–6.PubMedCrossRef Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991–6.PubMedCrossRef
57.
58.
Zurück zum Zitat Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–63.PubMedCrossRef Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–63.PubMedCrossRef
59.
Zurück zum Zitat Viechtbauer W. Conducting meta-analyses in R with the metafor package. Journal of Statistical Software. 2010;36(3):1–48.CrossRef Viechtbauer W. Conducting meta-analyses in R with the metafor package. Journal of Statistical Software. 2010;36(3):1–48.CrossRef
60.
Zurück zum Zitat Ioannidis JP. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry. 2011;68(8):773–80.PubMedCrossRef Ioannidis JP. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry. 2011;68(8):773–80.PubMedCrossRef
61.
Zurück zum Zitat Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4(3):245–53.PubMedCrossRef Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4(3):245–53.PubMedCrossRef
62.
Zurück zum Zitat Ioannidis JPA. Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol. 2013;57(5):184–7.CrossRef Ioannidis JPA. Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol. 2013;57(5):184–7.CrossRef
64.
Zurück zum Zitat Alizadeh S, Shab-Bidar S, Mohtavinejad N, Djafarian K. A posteriori dietary patterns and risk of pancreatic and renal cancers: a systematic review and meta-analysis. Nutr Food Sci. 2017;47(6):839–68.CrossRef Alizadeh S, Shab-Bidar S, Mohtavinejad N, Djafarian K. A posteriori dietary patterns and risk of pancreatic and renal cancers: a systematic review and meta-analysis. Nutr Food Sci. 2017;47(6):839–68.CrossRef
65.
Zurück zum Zitat Bai HW, Qian YY, Shi BY, Li G, Fan Y, Wang Z, et al. The association between fish consumption and risk of renal cancer: a meta-analysis of observational studies. PLoS One. 2013;8(11):e81939.PubMedPubMedCentralCrossRef Bai HW, Qian YY, Shi BY, Li G, Fan Y, Wang Z, et al. The association between fish consumption and risk of renal cancer: a meta-analysis of observational studies. PLoS One. 2013;8(11):e81939.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Boyle P, Koechlin A, Autier P. Sweetened carbonated beverage consumption and cancer risk: meta-analysis and review. Eur J Cancer Prev. 2014;23(5):481–90.PubMedCrossRef Boyle P, Koechlin A, Autier P. Sweetened carbonated beverage consumption and cancer risk: meta-analysis and review. Eur J Cancer Prev. 2014;23(5):481–90.PubMedCrossRef
67.
Zurück zum Zitat Cheng G, Xie L. Alcohol intake and risk of renal cell carcinoma: a meta-analysis of published case-control studies. Arch Med Sci. 2011;7(4):648–57.PubMedPubMedCentralCrossRef Cheng G, Xie L. Alcohol intake and risk of renal cell carcinoma: a meta-analysis of published case-control studies. Arch Med Sci. 2011;7(4):648–57.PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Clasen JL, Heath AK, Scelo G, Muller DC. Components of one-carbon metabolism and renal cell carcinoma: a systematic review and meta-analysis. Eur J Nutr. 2020;59(8):3801–13.PubMedPubMedCentralCrossRef Clasen JL, Heath AK, Scelo G, Muller DC. Components of one-carbon metabolism and renal cell carcinoma: a systematic review and meta-analysis. Eur J Nutr. 2020;59(8):3801–13.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Hu ZH, Lin YW, Xu X, Chen H, Mao YQ, Wu J, et al. No association between tea consumption and risk of renal cell carcinoma: a meta-analysis of epidemiological studies. Asian Pac J Cancer Prev. 2013;14(3):1691–5.PubMedCrossRef Hu ZH, Lin YW, Xu X, Chen H, Mao YQ, Wu J, et al. No association between tea consumption and risk of renal cell carcinoma: a meta-analysis of epidemiological studies. Asian Pac J Cancer Prev. 2013;14(3):1691–5.PubMedCrossRef
70.
Zurück zum Zitat Huang TB, Ding PP, Chen JF, Yan Y, Zhang L, Liu H, et al. Dietary fiber intake and risk of renal cell carcinoma: evidence from a meta-analysis. Med Oncol. 2014;31(8):125.PubMedCrossRef Huang TB, Ding PP, Chen JF, Yan Y, Zhang L, Liu H, et al. Dietary fiber intake and risk of renal cell carcinoma: evidence from a meta-analysis. Med Oncol. 2014;31(8):125.PubMedCrossRef
71.
Zurück zum Zitat Jayedi A, Emadi A, Shab-Bidar S. Dietary inflammatory index and site-specific cancer risk: a systematic review and dose-response meta-analysis. Adv Nutr. 2018;9(4):388–403.PubMedPubMedCentralCrossRef Jayedi A, Emadi A, Shab-Bidar S. Dietary inflammatory index and site-specific cancer risk: a systematic review and dose-response meta-analysis. Adv Nutr. 2018;9(4):388–403.PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Llaha F, Gil-Lespinard M, Unal P, de Villasante I, Castañeda J, Zamora-Ros R. Consumption of sweet beverages and cancer risk. A systematic review and meta-analysis of observational studies. Nutrients. 2021;13(2). Llaha F, Gil-Lespinard M, Unal P, de Villasante I, Castañeda J, Zamora-Ros R. Consumption of sweet beverages and cancer risk. A systematic review and meta-analysis of observational studies. Nutrients. 2021;13(2).
74.
Zurück zum Zitat Shen C, Huang Y, Yi S, Fang Z, Li L. Association of vitamin E intake with reduced risk of kidney cancer: a meta-analysis of observational studies. Med Sci Monit. 2015;21:3420–6.PubMedPubMedCentralCrossRef Shen C, Huang Y, Yi S, Fang Z, Li L. Association of vitamin E intake with reduced risk of kidney cancer: a meta-analysis of observational studies. Med Sci Monit. 2015;21:3420–6.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Wijarnpreecha K, Thongprayoon C, Thamcharoen N, Panjawatanan P, Cheungpasitporn W. Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis. Intern Med J. 2017;47(12):1422–32.PubMedCrossRef Wijarnpreecha K, Thongprayoon C, Thamcharoen N, Panjawatanan P, Cheungpasitporn W. Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis. Intern Med J. 2017;47(12):1422–32.PubMedCrossRef
76.
Zurück zum Zitat Wu J, Yang N, Yuan M. Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies. Int Braz J Urol. 2021;47(4):733–44.PubMedCrossRef Wu J, Yang N, Yuan M. Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies. Int Braz J Urol. 2021;47(4):733–44.PubMedCrossRef
77.
Zurück zum Zitat Xie L, Mo M, Jia HX, Liang F, Yuan J, Zhu J. Association between dietary nitrate and nitrite intake and sitespecific cancer risk: evidence from observational studies. Oncotarget. 2016;7(35):56915–32.PubMedPubMedCentralCrossRef Xie L, Mo M, Jia HX, Liang F, Yuan J, Zhu J. Association between dietary nitrate and nitrite intake and sitespecific cancer risk: evidence from observational studies. Oncotarget. 2016;7(35):56915–32.PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Xu X, Zhu Y, Li J, Wang S. Dietary fiber, glycemic index, glycemic load and renal cell carcinoma risk. Carcinogenesis. 2019;40(3):441–7.PubMedCrossRef Xu X, Zhu Y, Li J, Wang S. Dietary fiber, glycemic index, glycemic load and renal cell carcinoma risk. Carcinogenesis. 2019;40(3):441–7.PubMedCrossRef
79.
Zurück zum Zitat Xu X, Zhu Y, Zheng X, Xie L. Does beer, wine or liquor consumption correlate with the risk of renal cell carcinoma? A dose-response meta-analysis of prospective cohort studies. Oncotarget. 2015;6(15):13347–58.PubMedPubMedCentralCrossRef Xu X, Zhu Y, Zheng X, Xie L. Does beer, wine or liquor consumption correlate with the risk of renal cell carcinoma? A dose-response meta-analysis of prospective cohort studies. Oncotarget. 2015;6(15):13347–58.PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Zhang S, Jia Z, Yan Z, Yang J. Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies. Oncotarget. 2017;8(17):27892–903.PubMedPubMedCentralCrossRef Zhang S, Jia Z, Yan Z, Yang J. Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies. Oncotarget. 2017;8(17):27892–903.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Zhao J, Zhao L. Cruciferous vegetables intake is associated with lower risk of renal cell carcinoma: evidence from a meta-analysis of observational studies. PLoS One. 2013;8(10):e75732.PubMedPubMedCentralCrossRef Zhao J, Zhao L. Cruciferous vegetables intake is associated with lower risk of renal cell carcinoma: evidence from a meta-analysis of observational studies. PLoS One. 2013;8(10):e75732.PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Bellocco R, Pasquali E, Rota M, Bagnardi V, Tramacere I, Scotti L, et al. Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis. Ann Oncol. 2012;23(9):2235–44.PubMedCrossRef Bellocco R, Pasquali E, Rota M, Bagnardi V, Tramacere I, Scotti L, et al. Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis. Ann Oncol. 2012;23(9):2235–44.PubMedCrossRef
83.
Zurück zum Zitat Huang TB, Guo ZF, Zhang XL, Zhang XP, Liu H, Geng J, et al. Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies. Int Urol Nephrol. 2014;46(8):1481–93.PubMedCrossRef Huang TB, Guo ZF, Zhang XL, Zhang XP, Liu H, Geng J, et al. Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies. Int Urol Nephrol. 2014;46(8):1481–93.PubMedCrossRef
84.
Zurück zum Zitat Liu B, Mao Q, Wang X, Zhou F, Luo J, Wang C, et al. Cruciferous vegetables consumption and risk of renal cell carcinoma: a meta-analysis. Nutr Cancer. 2013;65(5):668–76.PubMedCrossRef Liu B, Mao Q, Wang X, Zhou F, Luo J, Wang C, et al. Cruciferous vegetables consumption and risk of renal cell carcinoma: a meta-analysis. Nutr Cancer. 2013;65(5):668–76.PubMedCrossRef
85.
Zurück zum Zitat Shang Y, Yi S, Cui D, Han G, Liu C. Vitamin E intake and risk of renal cell carcinoma: a meta-analysis of 7 case-control studies. J Ren Nutr. 2015;25(4):339–44.PubMedCrossRef Shang Y, Yi S, Cui D, Han G, Liu C. Vitamin E intake and risk of renal cell carcinoma: a meta-analysis of 7 case-control studies. J Ren Nutr. 2015;25(4):339–44.PubMedCrossRef
88.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, nutrition, physical activity and kidney cancer. 2018 [Available from: dietandcancerreport.org]. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, nutrition, physical activity and kidney cancer. 2018 [Available from: dietandcancerrep​ort.​org].
89.
Zurück zum Zitat Adams VR, Leggas M. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors. Clin Ther. 2007;29(7):1338–53.PubMedCrossRef Adams VR, Leggas M. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors. Clin Ther. 2007;29(7):1338–53.PubMedCrossRef
90.
91.
Zurück zum Zitat Bara T Jr, Gurzu S, Sugimura H, Bara T, Beleaua MA, Jung I. A systematic review of the possible carcinogenic role of the aristolochic acid. Rom J Morphol Embryol. 2017;58(1):41–4.PubMed Bara T Jr, Gurzu S, Sugimura H, Bara T, Beleaua MA, Jung I. A systematic review of the possible carcinogenic role of the aristolochic acid. Rom J Morphol Embryol. 2017;58(1):41–4.PubMed
92.
Zurück zum Zitat Biggar PH, Liangos O, Fey H, Brandenburg VM, Ketteler M. Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug? Pediatr Nephrol. 2011;26(1):7–18.PubMedCrossRef Biggar PH, Liangos O, Fey H, Brandenburg VM, Ketteler M. Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug? Pediatr Nephrol. 2011;26(1):7–18.PubMedCrossRef
93.
Zurück zum Zitat Caprio GG, Picascia D, Dallio M, Vitiello PP, Giunta EF, De Falco V, et al. Light alcohol drinking and the risk of cancer development: a controversial relationship. Rev Recent Clin Trials. 2020;15(3):164–77.PubMedCrossRef Caprio GG, Picascia D, Dallio M, Vitiello PP, Giunta EF, De Falco V, et al. Light alcohol drinking and the risk of cancer development: a controversial relationship. Rev Recent Clin Trials. 2020;15(3):164–77.PubMedCrossRef
95.
Zurück zum Zitat Fang J, Xu X, Mao Q, Ying Y, Zhang X, Xie L. Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: a meta-analysis. Int J Biol Markers. 2020;35(1):57–64.PubMedCrossRef Fang J, Xu X, Mao Q, Ying Y, Zhang X, Xie L. Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: a meta-analysis. Int J Biol Markers. 2020;35(1):57–64.PubMedCrossRef
96.
Zurück zum Zitat Fox CH, Eberl M. Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Complement Ther Med. 2002;10(4):229–34.PubMedCrossRef Fox CH, Eberl M. Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Complement Ther Med. 2002;10(4):229–34.PubMedCrossRef
97.
Zurück zum Zitat Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S. Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol. 2014;810:69–105.PubMed Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S. Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol. 2014;810:69–105.PubMed
98.
Zurück zum Zitat Gnagnarella P, Raimondi S, Aristarco V, Johansson HA, Bellerba F, Corso F, et al. Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol. 2020;1268:53–114.PubMedCrossRef Gnagnarella P, Raimondi S, Aristarco V, Johansson HA, Bellerba F, Corso F, et al. Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol. 2020;1268:53–114.PubMedCrossRef
99.
Zurück zum Zitat Gouveia MC, Vella JP, Cafeo FR, Affonso Fonseca FL, Bacci MR. Association between irisin and major chronic diseases: a review. Eur Rev Med Pharmacol Sci. 2016;20(19):4072–7.PubMed Gouveia MC, Vella JP, Cafeo FR, Affonso Fonseca FL, Bacci MR. Association between irisin and major chronic diseases: a review. Eur Rev Med Pharmacol Sci. 2016;20(19):4072–7.PubMed
100.
Zurück zum Zitat Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM. Dietary acrylamide intake and risk of renal cell carcinoma in two large prospective cohorts. Cancer Epidemiol Biomarkers Prev. 2018;27(8):979–82.PubMedPubMedCentralCrossRef Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM. Dietary acrylamide intake and risk of renal cell carcinoma in two large prospective cohorts. Cancer Epidemiol Biomarkers Prev. 2018;27(8):979–82.PubMedPubMedCentralCrossRef
101.
Zurück zum Zitat Händel MN, Cardoso I, Rasmussen KM, Rohde JF, Jacobsen R, Nielsen SM, et al. Processed meat intake and chronic disease morbidity and mortality: an overview of systematic reviews and meta-analyses. PLoS One. 2019;14(10):e0223883.PubMedPubMedCentralCrossRef Händel MN, Cardoso I, Rasmussen KM, Rohde JF, Jacobsen R, Nielsen SM, et al. Processed meat intake and chronic disease morbidity and mortality: an overview of systematic reviews and meta-analyses. PLoS One. 2019;14(10):e0223883.PubMedPubMedCentralCrossRef
102.
Zurück zum Zitat Il'yasova D, Schwartz GG. Cadmium and renal cancer. Toxicol Appl Pharmacol. 2005;207(2):179–86.PubMedCrossRef Il'yasova D, Schwartz GG. Cadmium and renal cancer. Toxicol Appl Pharmacol. 2005;207(2):179–86.PubMedCrossRef
103.
Zurück zum Zitat Jeyaraman MM, Abou-Setta AM, Grant L, Farshidfar F, Copstein L, Lys J, et al. Dairy product consumption and development of cancer: an overview of reviews. BMJ Open. 2019;9(1):e023625.PubMedPubMedCentralCrossRef Jeyaraman MM, Abou-Setta AM, Grant L, Farshidfar F, Copstein L, Lys J, et al. Dairy product consumption and development of cancer: an overview of reviews. BMJ Open. 2019;9(1):e023625.PubMedPubMedCentralCrossRef
104.
Zurück zum Zitat Kabaria R, Klaassen Z, Terris MK. Renal cell carcinoma: links and risks. Int J Nephrol Renovasc Dis. 2016;9:45–52.PubMedPubMedCentral Kabaria R, Klaassen Z, Terris MK. Renal cell carcinoma: links and risks. Int J Nephrol Renovasc Dis. 2016;9:45–52.PubMedPubMedCentral
105.
106.
Zurück zum Zitat Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004;7(1a):187–200.PubMedCrossRef Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004;7(1a):187–200.PubMedCrossRef
107.
Zurück zum Zitat Khan MI, Bielecka ZF, Najm MZ, Bartnik E, Czarnecki JS, Czarnecka AM, et al. Vitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approaches (review). Int J Oncol. 2014;44(2):349–63.PubMedCrossRef Khan MI, Bielecka ZF, Najm MZ, Bartnik E, Czarnecki JS, Czarnecka AM, et al. Vitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approaches (review). Int J Oncol. 2014;44(2):349–63.PubMedCrossRef
108.
Zurück zum Zitat Krajewski W, Dzięgała M, Kołodziej A, Dembowski J, Zdrojowy R. Vitamin D and urological cancers. Cent European J Urol. 2016;69(2):139–47.PubMedPubMedCentral Krajewski W, Dzięgała M, Kołodziej A, Dembowski J, Zdrojowy R. Vitamin D and urological cancers. Cent European J Urol. 2016;69(2):139–47.PubMedPubMedCentral
109.
Zurück zum Zitat Kume H, Takahashi S, Teramoto S, Isurugi K. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int. 2001;88(7):804.PubMed Kume H, Takahashi S, Teramoto S, Isurugi K. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int. 2001;88(7):804.PubMed
110.
Zurück zum Zitat Latino-Martel P, Cottet V, Druesne-Pecollo N, Pierre FH, Touillaud M, Touvier M, et al. Alcoholic beverages, obesity, physical activity and other nutritional factors, and cancer risk: a review of the evidence. Crit Rev Oncol Hematol. 2016;99:308–23.PubMedCrossRef Latino-Martel P, Cottet V, Druesne-Pecollo N, Pierre FH, Touillaud M, Touvier M, et al. Alcoholic beverages, obesity, physical activity and other nutritional factors, and cancer risk: a review of the evidence. Crit Rev Oncol Hematol. 2016;99:308–23.PubMedCrossRef
111.
Zurück zum Zitat Lenko V, Bialesova L, Macejova D, Bujdak P, Breza J, Brtko J. The relationship between renal cell carcinoma and nuclear retinoid/rexinoid receptors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(4):316–24.PubMedCrossRef Lenko V, Bialesova L, Macejova D, Bujdak P, Breza J, Brtko J. The relationship between renal cell carcinoma and nuclear retinoid/rexinoid receptors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(4):316–24.PubMedCrossRef
112.
Zurück zum Zitat Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615–21.PubMedCrossRef Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615–21.PubMedCrossRef
113.
Zurück zum Zitat Luong K, Nguyen LT. The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol. 2010;73(3):192–201.PubMedCrossRef Luong K, Nguyen LT. The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol. 2010;73(3):192–201.PubMedCrossRef
114.
Zurück zum Zitat Miller PE, Snyder DC. Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Pract. 2012;27(5):599–612.PubMedCrossRef Miller PE, Snyder DC. Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Pract. 2012;27(5):599–612.PubMedCrossRef
115.
Zurück zum Zitat Niu X, Zhu Z, Bao J. Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta-analysis. Cancer Cell Int. 2021;21(1):126.PubMedPubMedCentralCrossRef Niu X, Zhu Z, Bao J. Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta-analysis. Cancer Cell Int. 2021;21(1):126.PubMedPubMedCentralCrossRef
116.
Zurück zum Zitat Ouzzane A, Rouprêt M, Leon P, Yates DR, Colin P. Epidemiology and risk factors of upper urinary tract tumors: literature review for the yearly scientific report of the French National Association of Urology. Prog Urol. 2014;24(15):966–76.PubMedCrossRef Ouzzane A, Rouprêt M, Leon P, Yates DR, Colin P. Epidemiology and risk factors of upper urinary tract tumors: literature review for the yearly scientific report of the French National Association of Urology. Prog Urol. 2014;24(15):966–76.PubMedCrossRef
117.
Zurück zum Zitat Riboldi BP, Vinhas ÁM, Moreira JD. Risks of dietary acrylamide exposure: a systematic review. Food Chem. 2014;157:310–22.PubMedCrossRef Riboldi BP, Vinhas ÁM, Moreira JD. Risks of dietary acrylamide exposure: a systematic review. Food Chem. 2014;157:310–22.PubMedCrossRef
118.
Zurück zum Zitat Rumrich IK, Viluksela M, Vähäkangas K, Gissler M, Surcel HM, Hänninen O. Maternal smoking and the risk of cancer in early life - a meta-analysis. PLoS One. 2016;11(11):e0165040.PubMedPubMedCentralCrossRef Rumrich IK, Viluksela M, Vähäkangas K, Gissler M, Surcel HM, Hänninen O. Maternal smoking and the risk of cancer in early life - a meta-analysis. PLoS One. 2016;11(11):e0165040.PubMedPubMedCentralCrossRef
119.
120.
Zurück zum Zitat Ströhle A, Waldmann A, Wolters M, Hahn A. Vegetarian nutrition: Preventive potential and possible risks. Part 1: Plant foods. Wien Klin Wochenschr. 2006;118(19-20):580–93.PubMedCrossRef Ströhle A, Waldmann A, Wolters M, Hahn A. Vegetarian nutrition: Preventive potential and possible risks. Part 1: Plant foods. Wien Klin Wochenschr. 2006;118(19-20):580–93.PubMedCrossRef
121.
Zurück zum Zitat Teissedre PL, Rasines-Perea Z, Ruf JC, Stockley C, Antoce AO, Romano R, et al. Effects of alcohol consumption in general, and wine in particular, on the risk of cancer development: a review. OENE One. 2020;54(4):813–32.CrossRef Teissedre PL, Rasines-Perea Z, Ruf JC, Stockley C, Antoce AO, Romano R, et al. Effects of alcohol consumption in general, and wine in particular, on the risk of cancer development: a review. OENE One. 2020;54(4):813–32.CrossRef
122.
Zurück zum Zitat Virk-Baker MK, Nagy TR, Barnes S, Groopman J. Dietary acrylamide and human cancer: a systematic review of literature. Nutr Cancer. 2014;66(5):774–90.PubMedPubMedCentralCrossRef Virk-Baker MK, Nagy TR, Barnes S, Groopman J. Dietary acrylamide and human cancer: a systematic review of literature. Nutr Cancer. 2014;66(5):774–90.PubMedPubMedCentralCrossRef
123.
Zurück zum Zitat Weikert S, Ljungberg B. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol. 2010;28(3):247–52.PubMedCrossRef Weikert S, Ljungberg B. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol. 2010;28(3):247–52.PubMedCrossRef
124.
Zurück zum Zitat Wu F, Wang T. Risk assessment of upper tract urothelial carcinoma related to aristolochic acid. Cancer Epidemiol Biomarkers Prev. 2013;22(5):812–20.PubMedPubMedCentralCrossRef Wu F, Wang T. Risk assessment of upper tract urothelial carcinoma related to aristolochic acid. Cancer Epidemiol Biomarkers Prev. 2013;22(5):812–20.PubMedPubMedCentralCrossRef
125.
Zurück zum Zitat Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA. Systematic review of modifiable risk factors for kidney cancer. Urol Oncol. 2019;37(6):359–71.PubMedCrossRef Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA. Systematic review of modifiable risk factors for kidney cancer. Urol Oncol. 2019;37(6):359–71.PubMedCrossRef
126.
Zurück zum Zitat Darling AL, Abar L, Norat T. WCRF-AICR continuous update project: Systematic literature review of prospective studies on circulating 25-hydroxyvitamin D and kidney cancer risk. J Steroid Biochem Mol Biol. 2016;164:85–9.PubMedCrossRef Darling AL, Abar L, Norat T. WCRF-AICR continuous update project: Systematic literature review of prospective studies on circulating 25-hydroxyvitamin D and kidney cancer risk. J Steroid Biochem Mol Biol. 2016;164:85–9.PubMedCrossRef
127.
Zurück zum Zitat Dhote R, Thiounn N, Debré B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma. Urol Clin North Am. 2004;31(2):237–47.PubMedCrossRef Dhote R, Thiounn N, Debré B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma. Urol Clin North Am. 2004;31(2):237–47.PubMedCrossRef
128.
Zurück zum Zitat Dhôte R, Pellicer-Coeuret M, Thiounn N, Debré B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int. 2000;86(1):20–7.PubMedCrossRef Dhôte R, Pellicer-Coeuret M, Thiounn N, Debré B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int. 2000;86(1):20–7.PubMedCrossRef
129.
Zurück zum Zitat Javed F, Bello Correra FO, Chotai M, Tappuni AR, Almas K. Systemic conditions associated with areca nut usage: a literature review. Scand J Public Health. 2010;38(8):838–44.PubMedCrossRef Javed F, Bello Correra FO, Chotai M, Tappuni AR, Almas K. Systemic conditions associated with areca nut usage: a literature review. Scand J Public Health. 2010;38(8):838–44.PubMedCrossRef
130.
Zurück zum Zitat Jiang F, Teng M, Zhu YX, Li YJ. No association between dietary acrylamide and renal cell carcinoma: an updated meta-analysis. J Sci Food Agric. 2020;100(7):3071–7.PubMedCrossRef Jiang F, Teng M, Zhu YX, Li YJ. No association between dietary acrylamide and renal cell carcinoma: an updated meta-analysis. J Sci Food Agric. 2020;100(7):3071–7.PubMedCrossRef
131.
Zurück zum Zitat Johnson C, Raj TS, Trudeau L, Bacon SL, Padwal R, Webster J, et al. The science of salt: a systematic review of clinical salt studies 2013 to 2014. J Clin Hypertens (Greenwich). 2015;17(5):401–11.PubMedCentralCrossRef Johnson C, Raj TS, Trudeau L, Bacon SL, Padwal R, Webster J, et al. The science of salt: a systematic review of clinical salt studies 2013 to 2014. J Clin Hypertens (Greenwich). 2015;17(5):401–11.PubMedCentralCrossRef
132.
Zurück zum Zitat Kim JY, Kwon O. Garlic intake and cancer risk: an analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr. 2009;89(1):257–64.PubMedCrossRef Kim JY, Kwon O. Garlic intake and cancer risk: an analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr. 2009;89(1):257–64.PubMedCrossRef
133.
Zurück zum Zitat Lin G, Ning L, Gu D, Li S, Yu Z, Long Q, et al. Examining the association of circulating 25-hydroxyvitamin D with kidney cancer risk: a meta-analysis. Int J Clin Exp Med. 2015;8(11):20499–507.PubMedPubMedCentral Lin G, Ning L, Gu D, Li S, Yu Z, Long Q, et al. Examining the association of circulating 25-hydroxyvitamin D with kidney cancer risk: a meta-analysis. Int J Clin Exp Med. 2015;8(11):20499–507.PubMedPubMedCentral
134.
Zurück zum Zitat Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176(6 Pt 1):2353–8.PubMedCrossRef Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176(6 Pt 1):2353–8.PubMedCrossRef
135.
Zurück zum Zitat Mao B, Li Y, Zhang Z, Chen C, Chen Y, Ding C, et al. One-carbon metabolic factors and risk of renal cell cancer: a meta-analysis. PLoS One. 2015;10(10):e0141762.PubMedPubMedCentralCrossRef Mao B, Li Y, Zhang Z, Chen C, Chen Y, Ding C, et al. One-carbon metabolic factors and risk of renal cell cancer: a meta-analysis. PLoS One. 2015;10(10):e0141762.PubMedPubMedCentralCrossRef
136.
Zurück zum Zitat Pelucchi C, Bosetti C, Galeone C, La Vecchia C. Dietary acrylamide and cancer risk: an updated meta-analysis. Int J Cancer. 2015;136(12):2912–22.PubMedCrossRef Pelucchi C, Bosetti C, Galeone C, La Vecchia C. Dietary acrylamide and cancer risk: an updated meta-analysis. Int J Cancer. 2015;136(12):2912–22.PubMedCrossRef
137.
Zurück zum Zitat Pelucchi C, La Vecchia C, Bosetti C, Boyle P, Boffetta P. Exposure to acrylamide and human cancer--a review and meta-analysis of epidemiologic studies. Ann Oncol. 2011;22(7):1487–99.PubMedCrossRef Pelucchi C, La Vecchia C, Bosetti C, Boyle P, Boffetta P. Exposure to acrylamide and human cancer--a review and meta-analysis of epidemiologic studies. Ann Oncol. 2011;22(7):1487–99.PubMedCrossRef
138.
Zurück zum Zitat Rosato V, Negri E, Serraino D, Montella M, Libra M, Lagiou P, et al. Processed meat and risk of renal cell and bladder cancers. Nutr Cancer. 2018;70(3):418–24.PubMedCrossRef Rosato V, Negri E, Serraino D, Montella M, Libra M, Lagiou P, et al. Processed meat and risk of renal cell and bladder cancers. Nutr Cancer. 2018;70(3):418–24.PubMedCrossRef
139.
Zurück zum Zitat Yip CSC, Chan W, Fielding R. The associations of fruit and vegetable intakes with burden of diseases: a systematic review of meta-analyses. J Acad Nutr Diet. 2019;119(3):464–81.PubMedCrossRef Yip CSC, Chan W, Fielding R. The associations of fruit and vegetable intakes with burden of diseases: a systematic review of meta-analyses. J Acad Nutr Diet. 2019;119(3):464–81.PubMedCrossRef
141.
Zurück zum Zitat Navai N, Wood CG. Environmental and modifiable risk factors in renal cell carcinoma. Urol Oncol. 2012;30(2):220–4.PubMedCrossRef Navai N, Wood CG. Environmental and modifiable risk factors in renal cell carcinoma. Urol Oncol. 2012;30(2):220–4.PubMedCrossRef
142.
Zurück zum Zitat Washio M, Mori M. Risk factors for kidney cancer (renal cell carcinoma) in a Japanese population: a mini-review. International Medical Journal. 2011;18(3):220–3. Washio M, Mori M. Risk factors for kidney cancer (renal cell carcinoma) in a Japanese population: a mini-review. International Medical Journal. 2011;18(3):220–3.
143.
Zurück zum Zitat Boeing H, Schlehofer B, Wahrendorf J. Diet, obesity and risk for renal cell carcinoma: results from a case control-study in Germany. Z Ernahrungswiss. 1997;36(1):3–11.PubMedCrossRef Boeing H, Schlehofer B, Wahrendorf J. Diet, obesity and risk for renal cell carcinoma: results from a case control-study in Germany. Z Ernahrungswiss. 1997;36(1):3–11.PubMedCrossRef
144.
Zurück zum Zitat Gallicchio L, Moore LE, Stevens VL, Ahn J, Albanes D, Hartmuller V, et al. Circulating 25-hydroxyvitamin D and risk of kidney cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol. 2010;172(1):47–57.PubMedPubMedCentralCrossRef Gallicchio L, Moore LE, Stevens VL, Ahn J, Albanes D, Hartmuller V, et al. Circulating 25-hydroxyvitamin D and risk of kidney cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol. 2010;172(1):47–57.PubMedPubMedCentralCrossRef
146.
Zurück zum Zitat Ljungberg B, Albiges L, Bedke J, Bex A, Capitanio U, Giles RH, et al. EAU – ESTRO – ESUR – SIOG Guidelines on Renal Cell Carcinoma. Edn. presented at the EAU Annual Congress Milan 2021. Arnhem, The Netherlands: EAU Guidelines Office; 2021. Ljungberg B, Albiges L, Bedke J, Bex A, Capitanio U, Giles RH, et al. EAU – ESTRO – ESUR – SIOG Guidelines on Renal Cell Carcinoma. Edn. presented at the EAU Annual Congress Milan 2021. Arnhem, The Netherlands: EAU Guidelines Office; 2021.
147.
Zurück zum Zitat Bradlee ML, Singer MR, Qureshi MM, Moore LL. Food group intake and central obesity among children and adolescents in the Third National Health and Nutrition Examination Survey (NHANES III). Public Health Nutr. 2010;13(6):797–805.PubMedCrossRef Bradlee ML, Singer MR, Qureshi MM, Moore LL. Food group intake and central obesity among children and adolescents in the Third National Health and Nutrition Examination Survey (NHANES III). Public Health Nutr. 2010;13(6):797–805.PubMedCrossRef
148.
Zurück zum Zitat Silva D, Cunha KAD, Segheto W, Reis VG, Coelho FA, Morais SHO, et al. Behavioral patterns that increase or decrease risk of abdominal adiposity in adults. Nutr Hosp. 2018;35(1):90–7.PubMedCrossRef Silva D, Cunha KAD, Segheto W, Reis VG, Coelho FA, Morais SHO, et al. Behavioral patterns that increase or decrease risk of abdominal adiposity in adults. Nutr Hosp. 2018;35(1):90–7.PubMedCrossRef
149.
Zurück zum Zitat Koebnick C, Black MH, Wu J, Shu YH, MacKay AW, Watanabe RM, et al. A diet high in sugar-sweetened beverage and low in fruits and vegetables is associated with adiposity and a pro-inflammatory adipokine profile. Br J Nutr. 2018;120(11):1230–9.PubMedPubMedCentralCrossRef Koebnick C, Black MH, Wu J, Shu YH, MacKay AW, Watanabe RM, et al. A diet high in sugar-sweetened beverage and low in fruits and vegetables is associated with adiposity and a pro-inflammatory adipokine profile. Br J Nutr. 2018;120(11):1230–9.PubMedPubMedCentralCrossRef
150.
Zurück zum Zitat Dreher ML, Ford NA. A comprehensive critical assessment of increased fruit and vegetable intake on weight loss in women. Nutrients. 2020;12(7). Dreher ML, Ford NA. A comprehensive critical assessment of increased fruit and vegetable intake on weight loss in women. Nutrients. 2020;12(7).
151.
Zurück zum Zitat Takagi T, Hayashi R, Nakai Y, Okada S, Miyashita R, Yamada M, et al. Dietary intake of carotenoid-rich vegetables reduces visceral adiposity in obese Japanese men-a randomized, double-blind trial. Nutrients. 2020;12(8). Takagi T, Hayashi R, Nakai Y, Okada S, Miyashita R, Yamada M, et al. Dietary intake of carotenoid-rich vegetables reduces visceral adiposity in obese Japanese men-a randomized, double-blind trial. Nutrients. 2020;12(8).
152.
Zurück zum Zitat Zhang Y. Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res. 2004;555(1-2):173–90.PubMedCrossRef Zhang Y. Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res. 2004;555(1-2):173–90.PubMedCrossRef
153.
Zurück zum Zitat Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134(12 Suppl):3479s-85s. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134(12 Suppl):3479s-85s.
154.
Zurück zum Zitat Tang L, Zhang Y. Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab. 2004;5(2):193–201.PubMedCrossRef Tang L, Zhang Y. Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab. 2004;5(2):193–201.PubMedCrossRef
155.
Zurück zum Zitat Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A. 1992;89(6):2399–403.PubMedPubMedCentralCrossRef Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A. 1992;89(6):2399–403.PubMedPubMedCentralCrossRef
156.
Zurück zum Zitat Conaway CC, Getahun SM, Liebes LL, Pusateri DJ, Topham DK, Botero-Omary M, et al. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr Cancer. 2000;38(2):168–78.PubMedCrossRef Conaway CC, Getahun SM, Liebes LL, Pusateri DJ, Topham DK, Botero-Omary M, et al. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr Cancer. 2000;38(2):168–78.PubMedCrossRef
157.
Zurück zum Zitat Mahéo K, Morel F, Langouët S, Kramer H, Le Ferrec E, Ketterer B, et al. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 1997;57(17):3649–52.PubMed Mahéo K, Morel F, Langouët S, Kramer H, Le Ferrec E, Ketterer B, et al. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 1997;57(17):3649–52.PubMed
158.
Zurück zum Zitat Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, et al. Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther. 2006;5(4):935–44.PubMedCrossRef Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, et al. Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther. 2006;5(4):935–44.PubMedCrossRef
159.
Zurück zum Zitat Tang L, Zhang Y. Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther. 2005;4(8):1250–9.PubMedCrossRef Tang L, Zhang Y. Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther. 2005;4(8):1250–9.PubMedCrossRef
160.
Zurück zum Zitat Tang L, Zhang Y. Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr. 2004;134(8):2004–10.PubMedCrossRef Tang L, Zhang Y. Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr. 2004;134(8):2004–10.PubMedCrossRef
161.
Zurück zum Zitat Tang L, Li G, Song L, Zhang Y. The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs. 2006;17(3):297–305.PubMedCrossRef Tang L, Li G, Song L, Zhang Y. The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs. 2006;17(3):297–305.PubMedCrossRef
162.
Zurück zum Zitat Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene. 2001;20(23):2927–36.PubMedCrossRef Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene. 2001;20(23):2927–36.PubMedCrossRef
163.
Zurück zum Zitat Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF, et al. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem. 1998;273(7):3838–47.PubMedCrossRef Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF, et al. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem. 1998;273(7):3838–47.PubMedCrossRef
164.
Zurück zum Zitat Mendoza-Pérez J, Gu J, Herrera LA, Tannir NM, Zhang S, Matin S, et al. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma. Cancer. 2017;123(18):3617–27.PubMedCrossRef Mendoza-Pérez J, Gu J, Herrera LA, Tannir NM, Zhang S, Matin S, et al. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma. Cancer. 2017;123(18):3617–27.PubMedCrossRef
165.
Zurück zum Zitat Shenoy N, Bhagat TD, Cheville J, Lohse C, Bhattacharyya S, Tischer A, et al. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma. J Clin Invest. 2019;129(4):1612–25.PubMedPubMedCentralCrossRef Shenoy N, Bhagat TD, Cheville J, Lohse C, Bhattacharyya S, Tischer A, et al. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma. J Clin Invest. 2019;129(4):1612–25.PubMedPubMedCentralCrossRef
166.
Zurück zum Zitat Shim EH, Livi CB, Rakheja D, Tan J, Benson D, Parekh V, et al. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 2014;4(11):1290–8.PubMedPubMedCentralCrossRef Shim EH, Livi CB, Rakheja D, Tan J, Benson D, Parekh V, et al. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 2014;4(11):1290–8.PubMedPubMedCentralCrossRef
168.
Zurück zum Zitat Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget. 2011;2(8):627–37.PubMedPubMedCentralCrossRef Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget. 2011;2(8):627–37.PubMedPubMedCentralCrossRef
169.
Zurück zum Zitat Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G, et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 2011;71(24):7360–5.PubMedPubMedCentralCrossRef Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G, et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 2011;71(24):7360–5.PubMedPubMedCentralCrossRef
170.
Zurück zum Zitat Kraus TF, Globisch D, Wagner M, Eigenbrod S, Widmann D, Münzel M, et al. Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors. Int J Cancer. 2012;131(7):1577-1590. Kraus TF, Globisch D, Wagner M, Eigenbrod S, Widmann D, Münzel M, et al. Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors. Int J Cancer. 2012;131(7):1577-1590.
171.
Zurück zum Zitat Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 2012;103(4):670–6.PubMedPubMedCentralCrossRef Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 2012;103(4):670–6.PubMedPubMedCentralCrossRef
172.
Zurück zum Zitat Okamoto K, Toyokuni S, Uchida K, Ogawa O, Takenewa J, Kakehi Y, et al. Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer. 1994;58(6):825–9.PubMedCrossRef Okamoto K, Toyokuni S, Uchida K, Ogawa O, Takenewa J, Kakehi Y, et al. Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer. 1994;58(6):825–9.PubMedCrossRef
173.
Zurück zum Zitat Umemura T, Sai K, Takagi A, Hasegawa R, Kurokawa Y. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis. 1990;11(2):345–7.PubMedCrossRef Umemura T, Sai K, Takagi A, Hasegawa R, Kurokawa Y. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis. 1990;11(2):345–7.PubMedCrossRef
174.
Zurück zum Zitat Daniel CR, Cross AJ, Graubard BI, Park Y, Ward MH, Rothman N, et al. Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am J Clin Nutr. 2012;95(1):155–62.PubMedCrossRef Daniel CR, Cross AJ, Graubard BI, Park Y, Ward MH, Rothman N, et al. Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am J Clin Nutr. 2012;95(1):155–62.PubMedCrossRef
175.
Zurück zum Zitat Karami S, Daugherty SE, Purdue MP. A prospective study of alcohol consumption and renal cell carcinoma risk. Int J Cancer. 2015;137(1):238–42.PubMedCrossRef Karami S, Daugherty SE, Purdue MP. A prospective study of alcohol consumption and renal cell carcinoma risk. Int J Cancer. 2015;137(1):238–42.PubMedCrossRef
176.
Zurück zum Zitat Lew JQ, Chow WH, Hollenbeck AR, Schatzkin A, Park Y. Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study. Br J Cancer. 2011;104(3):537–41.PubMedPubMedCentralCrossRef Lew JQ, Chow WH, Hollenbeck AR, Schatzkin A, Park Y. Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study. Br J Cancer. 2011;104(3):537–41.PubMedPubMedCentralCrossRef
177.
Zurück zum Zitat Macleod LC, Hotaling JM, Wright JL, Davenport MT, Gore JL, Harper J, et al. Risk factors for renal cell carcinoma in the VITAL study. J Urol. 2013;190(5):1657–61.PubMedPubMedCentralCrossRef Macleod LC, Hotaling JM, Wright JL, Davenport MT, Gore JL, Harper J, et al. Risk factors for renal cell carcinoma in the VITAL study. J Urol. 2013;190(5):1657–61.PubMedPubMedCentralCrossRef
178.
Zurück zum Zitat Papadimitriou N, Markozannes G, Kanellopoulou A, Critselis E, Alhardan S, Karafousia V, et al. An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun. 2021;12(1):4579.PubMedPubMedCentralCrossRef Papadimitriou N, Markozannes G, Kanellopoulou A, Critselis E, Alhardan S, Karafousia V, et al. An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun. 2021;12(1):4579.PubMedPubMedCentralCrossRef
179.
Zurück zum Zitat Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. Bmj. 2011;343:d4002.PubMedCrossRef Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. Bmj. 2011;343:d4002.PubMedCrossRef
180.
Zurück zum Zitat Teissedre P-L, Rasines-Perea Z, Ruf J-C, Stockley C, Antoce AO, Romano R, et al. Effects of alcohol consumption in general, and wine in particular, on the risk of cancer development: a review. OENE One. 2020;54(4):813–32.CrossRef Teissedre P-L, Rasines-Perea Z, Ruf J-C, Stockley C, Antoce AO, Romano R, et al. Effects of alcohol consumption in general, and wine in particular, on the risk of cancer development: a review. OENE One. 2020;54(4):813–32.CrossRef
181.
Zurück zum Zitat Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139(8):1069–79.PubMedCrossRef Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139(8):1069–79.PubMedCrossRef
Metadaten
Titel
The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies
verfasst von
Zhanchen Liao
Zhitao Fang
Siqi Gou
Yong Luo
Yiqi Liu
Zhun He
Xin Li
Yansong Peng
Zheng Fu
Dongjin Li
Haiyun Chen
Zhigang Luo
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Medicine / Ausgabe 1/2022
Elektronische ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-021-02229-5

Weitere Artikel der Ausgabe 1/2022

BMC Medicine 1/2022 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.